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The Munc13 proteins are the key mediators of synaptic vesicle priming, an essential 
step in Ca2+-regulated neurotransmitter release that renders docked vesicles fusion-
competent prior to exocytosis. They have emerged as important regulators of adaptive 
synaptic mechanisms such as presynaptic short-term plasticity, a process by which the 
release of neurotransmitter is dynamically adapted to a changing demand. Indeed, 
Munc13-1 and ubMunc13-2 contain a conserved calmodulin (CaM) binding site and the 
Ca2+-dependent interaction of these Munc13 isoforms with CaM constitutes a molecular 
mechanism that transduces residual Ca2+ signaling to the synaptic exocytotic machinery. 
This study aimed to (i) establish whether such regulation through CaM exists in the other 
Munc13 isoforms, bMunc13-2 and Munc13-3, and (ii) provide structural insights into the 
Munc13-CaM interaction. 
Bioinformatic tools were used to identify potential CaM recognition motifs in the non-
conserved sequences of bMunc13-2 and Munc13-3. Munc13-derived model peptides 
covering the potential CaM binding sites were used in photoaffinity labeling (PAL) 
experiments with CaM, followed by mass spectrometric characterization of the covalent 
photoadducts. Analysis of these peptide-protein interactions demonstrated that all four 
Munc13 isoforms bind CaM in a stoichiometric and Ca2+-dependent manner and that 
only slightly elevated intracellular Ca2+ concentrations are sufficient to trigger these 
interactions. These results support the conclusion that convergent evolution has 
generated structurally distinct but functionally similar Ca2+/CaM binding sites in Munc13-
1/ubMunc13-2, bMunc13-2, and Munc13-3, all of which can contribute to presynaptic 
short-term plasticity. 
A novel PAL-based analytical strategy using isotopically labeled CaM and mass 
spectrometry was established for the structural characterization of the covalent Munc13-
CaM photoadducts. It revealed that, in the bound state, the hydrophobic anchor residue 
of the CaM-binding motif in Munc13 contacts two distinct Met residues in the C-terminal 
domain of CaM. These contact sites provided a valuable basis for molecular modeling of 
the Munc13-CaM complex through integration with constraints obtained by chemical 
cross-linking methods. The PAL analysis, carried out under physiological solvent and 
concentration conditions, also emerged as an important complement to high-
resolution NMR studies on the Munc13/CaM interaction, as it yielded biochemical 
support for a novel 1-26 CaM binding motif in Munc13-1 and ubMunc13-2. The 
structural data on the Munc13-CaM complex offer new options for future studies 
towards a deeper understanding of the role of Munc13 proteins in synaptic vesicle 
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1.1. Basics of synaptic transmission 
The human brain is in all likelihood the most complex known biological system. It 
comprises a sophisticated network of many billions of neurons, the highly 
differentiated electrically excitable cells dedicated to the conduction, computation, 
storage and modulation of electrical information. Neuronal connectivity is the 
indispensable prerequisite for such complex tasks. It is achieved through an 
overwhelming number of synapses, the specialized regions of chemical contact 
between neurons. 
Chemical synapses are asymmetric transcellular junctions capable of converting the 
electrical activity of the presynaptic neuron into an extracellular chemical signal to be 
received by the postsynaptic neuron, a process termed synaptic transmission. 
Synaptic transmission is initiated by membrane depolarization waves that reach the 
presynapse in the form of action potentials. They induce the opening of voltage-
gated calcium ion (Ca
2+
) channels which triggers the Ca
2+
-dependent exocytosis of 
synaptic vesicles filled with chemical compounds - the neurotransmitters - into the 
intercellular cleft defined by the synapse. The neurotransmitters bind receptors at 
the postsynaptic membrane leading to a translation of this chemical signal back into 
an electrical signal within the postsynaptic neuron. 
Ca
2+
-dependent vesicular neurotransmitter release at neuronal synapses involves a 
specialized and tightly regulated form of Ca
2+
-triggered membrane fusion of 
exceptionally high spatial and temporal precision and speed. Transduction of the 
electric activity invading the synapse into synaptic vesicle fusion events takes place 
in less than 1 ms (Sabatini and Regehr, 1999), and is spatially restricted to the 
active zone, a defined electron-dense presynaptic membrane region equipped with a 
unique protein machinery mediating regulated exocytosis (Rosenmund et al., 2003). 
 
1.2. The synaptic vesicle cycle 
Synaptic vesicles pass through a complex cycle of membrane fusion and fission 
reactions in order to execute regulated neurotransmitter release. They bud from 
early endosomes, get loaded with neurotransmitter and are recruited to the plasma 
membrane, where they dock to the active zone. Once docked at the active zone, 
synaptic vesicles undergo maturation to a fusion-competent state (priming) that is 






leading to their fusion with the plasma membrane and secretion of neurotransmitter 
into the postsynaptic cleft. Following fusion the protein and membrane constituents 
of the synaptic vesicles are endocytosed and recycled (Fig. 1; Sudhof, 2004). 
 
 
Figure 1. The synaptic vesicle cycle. Synaptic vesicles get loaded with neurotransmitter by 
active transport and are translocated to the presynaptic plasma membrane and dock at the active 
zone. A priming/maturation step involving the Munc13 proteins (see text for details) renders them 
fusion-competent. Munc13s are modulated by calmodulin (CaM) in processes of short-term 
plasticity (Junge et al., 2004). Ca
2+
-triggered exocytosis leads to neurotransmitter release into the 
synaptic cleft. Synaptic vesicles are recycled via clathrin-mediated endocytosis or through a 
direct step bypassing endosomal intermediates. NT, neurotransmitter. Adapted from Brose et al., 
2000. 
 
Synaptic vesicle priming emerged as a concept from electrophysiological and 
morphological observations that repetitive stimulation can functionally exhaust 
synapses (i.e. leading to decelerated exocytosis) before causing a decrease in  the 
number of docked vesicles (Sudhof, 1995). The need for such a vesicle maturation 
step is supported by the fact that neurotransmitter release takes place only 200 s 
following Ca
2+
 influx (Llinás et al., 1981). Such fast coupling between excitation and 
secretion is only feasible when the essential parts of the protein machinery required 
for Ca
2+
-induced membrane fusion are already assembled (Sudhof, 1995; Sudhof, 
2004; Wojcik and Brose, 2007). In the past decade the Munc13 proteins have been 






1.3. The Munc13 protein family 
The Munc13 proteins were identified as mammalian homologues of the 
Caenorhabditis elegans Unc-13 proteins, initially discovered in a genetic screen for 
mutations leading to an uncoordinated (unc) phenotype in worms. The unc-13 
mutant worms were paralyzed, suffered irregular pharyngeal movements, and were 
characterized by an abnormal accumulation of acetylcholine and resistance to 
acetyltransferase inhibitors, features suggestive of compromised neurotransmitter 
release (Brenner, 1974). At least two splice variants of a single unc-13 gene are 
expressed In C. elegans and three splice variants have been identified in D. 
melanogaster (Aravamudan et al., 1999; Maruyama and Brenner, 1991; Richmond 
et al., 1999; Xu et al., 1998). Mammals have three different Munc13 genes (Munc13-
1, Munc13-2 and Munc13-3; (Augustin et al., 1999a; Brose et al., 1995b) and two 
more distantly related Munc13-like genes, Munc13-4 and Baiap3 (Koch et al., 2000). 
Expression of Munc13-1 and Munc13-3 is restricted to neurons and neuroendocrine 
cells, while Munc13-2 is present as a brain-specific (bMunc13-2) and a ubiquitously 




Figure 2. Domain structure of the Munc13 protein family. All Munc13 proteins share a highly 
homologous C-terminus (R-region, red) containing two Munc13 homology domains (MHDs), one 
diacyglycerol/phorbolester binding C1 domain, and two C2 domains. C. elegans Unc-13 (ce-unc-
13) is expressed as two splice variants (MR and LR). Only the mammalian homologs Munc13-1 
and ubMunc13-2 share homology with the ce-Unc-13 LR protein N-terminally of the C1 domain 
(L-region, blue). The N-termini of bMunc13-2 (green) and Munc13-3 (yellow) and the D. 
melanogaster isoform dr-unc-13 (orange) are unrelated. A highly acidic stretch in the N-terminus 
of Munc13-1 (white) is not conserved in ubMunc13-2. The established conserved CaM binding 






Structurally, Munc13 proteins are characterized by their highly conserved C-terminal 
parts, which contain a C1 domain, two C2 domains, and two Munc13 homology 
domains (MHDs) (Fig. 2). A combination of ultrastructural, biochemical, cell 
biological and electrophysiological methods have established the C1 domain of 
Munc13-1 as a functional target of the DAG second messenger pathway, where 
Munc13-1 acts as a presynaptic phorbol ester/DAG receptor and can translocate to 
the membrane in a PKC-independent manner to enhance neurotransmitter release 
(Ashery et al., 2000; Betz et al., 1998). C2 domains are found in many proteins as 
modules for Ca
2+
-dependent phospholipid or protein interactions (Brose et al., 
1995a) but such functions of the C2 domains in the Munc13 proteins have not been 
established so far. The MHD regions present in the conserved C-termini of all 
Munc13 isoforms convey the priming function to these proteins as they are sufficient 
to rescue neurotransmitter release in hippocampal neurons of Munc13-1/2 knockout 
mice (Basu et al., 2005; Stevens et al., 2005). 
In contrast to the evolutionarily conserved C-termini across the Unc13 family, the N-
terminal parts of the proteins are largely unrelated and only Munc13-1 and 
ubMunc13-2 share homology with the amino-terminus of the longer Unc-13 splice 
variant in C. elegans. The N-terminal sequences of bMunc13-2 and Munc13-3 are 
not homologous to each other or to other known proteins. Such structural distinction 
between conserved and variable modules in the Munc13 protein family indicates that 
while all isoforms are capable of promoting synaptic vesicle priming (through 
interactions taking place in the C-terminus of the proteins) they may be subject to 
differential regulation (defined by their variable N-termini). 
Munc13-1 is highly expressed throughout the rodent brain, while Munc13-2 and 
Munc13-3 exhibit complementary expression patterns. Munc13-2 is only present in 
rostral brain regions, including cerebral cortex and ‘cornu ammonis’ regions of the 
hippocampus, and Munc13-3 expression is restricted to the cerebellum in regions of 
high synaptic density (Augustin et al., 1999a). 
Genetic studies have established the significance of Munc13-1 in both spontaneous 
and evoked neurotransmitter release. Morphological and electrophysiological 
analysis of individual primary neurons of mice lacking Munc13-1 showed its 
essential role as a molecular factor in the priming of synaptic vesicles. Loss of 
Munc13-1 leads to a 90% reduction of the pool of readily-releasable vesicles and 
thus to a significant decrease in neurotransmitter release (Fig. 3A) (Augustin et al., 




gene abolished neurotransmitter release at the neuromuscular junction. Unc13 
appeared essential to the fusion competence of GABAergic and cholinergic synaptic 
vesicles (Aravamudan et al., 1999; Richmond et al., 1999). Ablations of Munc13-2 or 
Munc13-3 in mice do not cause significant anatomical, morphological or 
ultrastructural changes in the brain or a severe behavioral phenotype, indicating a 
compensatory role for the Munc13-1 isoform. Hippocampal neurons from animals 
lacking both Munc13-1 and Munc13-2 are completely deficient in transmitter release 
underscoring the indispensable role of the Munc13 proteins for proper neuronal 
function (Fig. 3B; Varoqueaux et al., 2002).  
 
 
Figure 3. Electrophysiological characterization of Munc13-deficient mice. (A) Excitatory 
postsynaptic currents (EPSCs) recorded from primary autaptic wild type (WT) and Munc13-1 
knockout (KO) hippocampal neurons by application of hypertonic sucrose solution showing a 90 
% decrease in the size of readily releasable vesicle pool at glutamatergic synapses lacking 
Munc13-1. (B) Evoked EPSCs from Munc13-2 KO neurons were similar to WT, while Munc13-1 
deletion led to a 90% reduction of evoked transmitter release. Hippocampal neurons lacking both 
Munc13-1 and Munc13-2 show neither evoked nor spontaneous release events. Adapted from 
Augustin et al., 1999b (A) and Varoqueaux et al., 2002 (B). 
 
The syntaxin binding properties of Munc13 proteins have been considered essential 
for their role in synaptic vesicle priming (Brose et al., 2000). Syntaxin is a 
presynaptic membrane protein constituent of the fusogenic SNARE (soluble N-
ethylmaleimide-sensitive factor attachment protein receptor) complex that is required 
for the Ca
2+
-triggered synaptic vesicle fusion (Jahn and Südhof, 1999). The 
observation that a constitutively open syntaxin mutant can partially restore 
neurotransmitter release in unc-13 knockout nematodes indicated that unc-
13/Munc13s may play a role in the conformational transition of syntaxin-1 




interaction between Munc13 and the N-terminal region of syntaxin-1 (Betz et al., 
1997), it was later found that purified Munc13-1 does not bind to isolated syntaxin-1 
(Basu et al., 2005), suggesting that additional factors or proteins, such as tomosyn 
may be mediating this interaction (Gracheva et al., 2006; McEwen et al., 2006; 
Wojcik and Brose, 2007). 
 
1.4. Munc13 proteins and short-term synaptic plasticity 
Due to their essential function in synaptic vesicle priming and in the modulation of 
synaptic strength, Munc13 proteins have emerged as key regulators of adaptive 
synaptic mechanisms such as presynaptic short-term plasticity (STP). Short-term 
synaptic plasticity encompasses processes of activity-dependent modulation of 
neural networks and information processing in the CNS that occur on a timescale of 
milliseconds to minutes and typically reflect a rapid change in presynaptic transmitter 
release characteristics in response to acute changes in activity (Katz and Miledi, 
1968; Zucker and Regehr, 2002). STP can result in either synaptic enhancement or 
synaptic depression, responses that are strongly dependent on the initial efficiency 
with which synapses transduce action potentials into synaptic transmitter release. 
Synaptic enhancement is manifested in three possible ways depending on its 
duration — facilitation, augmentation, or posttetanic potentiation (PTP). STP can 
also reduce neurotransmission, resulting in synaptic depression (Zucker and 
Regehr, 2002). The molecular mechanisms underlying the various forms of short-
term plasticity are not completely understood, but it is generally accepted that most 
of them are Ca
2+
 dependent (Katz and Miledi, 1968; Zucker and Regehr, 2002). 
The initial hypothesis that residual Ca
2+
 build-up in the synapse after an action 
potential is responsible for the enhanced synaptic transmission has been supported 
by more recent experiments in which a slow Ca
2+
 chelator, EGTA, was introduced 
into the presynaptic terminal and caused reduction in synaptic enhancement 
(Korogod et al., 2005). Originally it was believed that residual Ca
2+
 from prior activity 
simply summates with subsequent presynaptic Ca
2+
 transients in order to increase 
the efficacy of release probability (Katz and Miledi, 1968). It is now generally 
accepted, however, that residual Ca
2+
 also acts specifically on Ca
2+
-binding proteins 
other than the sensor for neurotransmitter release, in order to alter release efficacy 
(Zucker and Regehr, 2002).  
Ca
2+
 could interfere with every step of the synaptic vesicle cycle to promote short-




may be caused by a direct effect of Ca
2+
 on molecular factors that regulate synaptic 
vesicle recruitment, docking, priming, fusion, and even endocytosis. Furthermore, 
elevation of presynaptic Ca
2+
 concentrations may regulate cytoskeletal elements and 
kinases/phosphatases that in turn modulate components of the synaptic release 
machinery (Rosenmund et al., 2002). In the search of molecular mechanisms 
underlying short-term plasticity events, the Munc13 proteins emerged as presynaptic 
factors to confer differential, isoform-specific presynaptic STP characteristics 
(Rosenmund et al., 2002). Functional studies on Munc13 knock-out neurons showed 
that Munc13-2 dependent synapses facilitate during trains of action potentials and 
show augmentation following high-frequency stimulation while Munc13-1-dependent 
synapses are characterized by short-term depression and no augmentation under 
the same stimulation conditions (Rosenmund et al., 2002). These results indicated a 
direct involvement of the Munc13 proteins in the mechanisms of STP.  
STP characteristics are mainly determined by the transient increase in the residual 
presynaptic Ca
2+
 levels (see section 1.4.). There is, however, no known direct Ca
2+
-
dependent regulation of the Munc13 proteins suggesting that an additional 
molecular link is needed to confer Ca
2+
 sensitivity upon Munc13s for STP. Such 
molecular link was recognized in calmodulin (CaM), as Junge and colleagues 
identified a CaM binding site in Munc13-1 and ubMunc13-2, and demonstrated that 
the Ca
2+
-dependent CaM binding of Munc13-1 and ubMunc13-2 generates a Ca
2+
 
sensor/effector complex linking residual Ca
2+
 signaling to the synaptic exocytotic 
machinery (Fig. 4) (Junge et al., 2004). Using synaptic depression, frequency 
facilitation and augmentation protocols in autaptic hippocampal neurons they 
showed that CaM binding to Munc13 proteins enhances priming activity and 













Figure 4. Altered short-term plasticity in glutamatergic autaptic Munc13-1/2 DKO neurons 
rescued with wild type or CaM-insensitive Munc13 variants.  (A) Short-term plasticity of 
autaptic Munc13-1/2 DKO neurons rescued with wild type (WT) Munc13-1 or CaM-insensitive 
Munc13-1W464R mutant. Cells rescued with Munc13-1W464R showed a stronger depression 
and lack of augmentation following high-frequency stimulation. (B) Short-term plasticity of 
autaptic Munc13-1/2 DKO neurons rescued with WT ubMunc13-2 or CaM-insensitive ubMunc13-
2W387R mutant. Cells rescued with WT ubMunc13-2 exhibited frequency facilitation and 
augmentation, while cells rescued with ubMunc13-2W387R showed depression and hardly any 





 and calmodulin in the brain 
Tight regulation of the cytosolic concentration of calcium ions is essential for the 
control of a wide range of biological processes, including muscle contraction, cell 
proliferation, apoptosis, fertilization, and neurotransmitter release. Many proteins 
involved in Ca
2+
 signal transduction alter their activity in response to changes in free 
Ca
2+
 levels, but are themselves unable to bind Ca
2+
 ions. In many of these cases, a 
modulatory function is carried out by calmodulin (CaM), an intracellular Ca
2+
 sensor 
with a multitude of known interactors (Ikura and Ames, 2006). 
Calmodulin (16.7 kDa) has one of the most conserved amino acid sequences across 
eukaryotes (Copley et al., 1999). It is a highly acidic protein (pI ~4.6), further 
characterized by an unusual abundance of Met residues (6.1% Met frequency in 
sequence). Structurally CaM contains N- and C-terminal globular domains 
connected by a flexible central linker. Each of the two globular lobes is made out of 
a pair of helix-loop-helix Ca
2+
 binding motifs (EF hands) accommodating a total of 4 
Ca
2+
 ions. The two EF hand pairs share a high degree of sequence homology. 
However, the subtle differences in sequence are sufficient to relay different Ca
2+
 
binding affinities to the N- and C-terminal lobes of CaM: the C-terminus binds Ca
2+
 
with a Kd  2  10-7 M, while the N-terminal lobe has a 10 times lower Ca2+ affinity 




conformations in the absence and presence of Ca
2+
 (Fig. 5). In apo-CaM, the N-
terminal domain adopts a closed arrangement in which the helices of both EF hands 
are packed tightly together while the C-terminus remains in a partially open 
conformation allowing some solvent access to its Met-rich hydrophobic binding 
patch (Swindells and Ikura, 1996). Binding of Ca
2+
 to the EF hands of CaM induces 
significant structural rearrangements in the relative orientation of the helices in each 
lobe, prompting the exposure of the several Met residues to the solvent that take 
part in interactions with CaM targets (Crivici and Ikura, 1995; Ikura, 1996). This 
property, in addition to the flexibility of the linker joining the two domains, confers 
upon CaM an extraordinary versatility in macromolecular interactions and the 








Figure 5. CaM structure and CaM-binding motifs. (A, B) Ribbon representation of CaM 
structure in Ca
2+
-free state (apo CaM, A) and with all 4 Ca
2+
-binding sites occupied (Ca
2+
/CaM, 
B). N-terminal lobe is oriented to the top. Met side chains (purple) define potential hydrophobic 
pockets in each of the two domains. Ca
2+
 binding to CaM induces conformational changes that 
lead to exposure of hydrophobic surfaces that take part in interactions with target proteins. (C) 
Different Ca
2+
-dependent CaM binding motifs with characteristic distribution of hydrophobic 
amino acids (D) Aligned sequences of known CaM binding motifs. Hydrophobic residues are 
shown in red and are numbered relative to the anchor residue in position one of the motif. 









Considering the extraordinarily high concentrations of CaM in the brain (10-100 M; 
Xia and Storm, 2005), it is not surprising that many of the known Ca
2+
-dependent 
CaM binding partners are neuronal proteins. However, the Ca
2+
 receptor essential 
for vesicle fusion is not calmodulin. Synaptotagmin, a low-Ca
2+
-affinity, C2-domain-
containing protein, is now well established as the Ca
2+
 sensor for fast 
neurotransmission (Geppert et al., 1994; Sudhof and Rizo, 1996). Calmodulin is 
involved, however, in controlling synaptic vesicle recruitment via activation of 
Ca
2+
/calmodulin-dependent protein kinases (CaMKs) I and II and the 
phosphorylation of the synapsins on the synaptic vesicle. Phosphorylated synapsins 
dissociate from the vesicle, which leads to release of synaptic vesicles from 
cytoskeletal attachment and their recruitment to the presynaptic plasma membrane 
(Benfenati et al., 1992; Hilfiker et al., 1999; Valtorta et al., 1992). Calmodulin is 
important in many other aspects of Ca
2+
-dependent modulation of neuronal function. 
These include post-synaptic changes during synaptic plasticity via the interaction of 
calmodulin with CaMKII (Malenka et al., 1989; Pettit et al., 1994), regulation of gene 
expression (Deisseroth et al., 1998), Ca
2+
-dependent inactivation of voltage-gated 
Ca
2+





 channels (Keen et al., 1999; Xia et al., 1998).  
 
Prominent examples of neuronal CaM targets include the Munc13 proteins, the key 
mediators of synaptic vesicle priming. Through extensive biochemical analysis the 
CaM binding sites of Munc13-1 and ubMunc13-2 were narrowed down to a highly 
homologous 21 amino acid stretch in the N-termini of the proteins. These CaM 
binding sites are defined by a conserved bulky hydrophobic anchor residue (Trp-464 
in Munc13-1 and Trp-387 in ubMunc13-2) and a high propensity to form a basic 
amphiphilic -helix – minimal requirements shared by most of the otherwise rather 
diverse Ca
2+






Figure 6. Helical wheel projections of the CaM binding site in Munc13-1 and ubMunc13-2 
and evolutionary conservation (A) Sequence alignment of CaM binding sites in Munc13/Unc-
13 homologs. Identical amino acids are boxed in black. Proposed hydrophobic anchor residues 
are shown in red, further hydrophobic residues with conserved distribution for CaM binding are 
shown in blue. (B) Amphipathic helices predicted in the CaM binding regions of Munc13-1 and 
ubMunc13-2 expose clusters of hydrophobic (gray circles) and hydrophilic (open circles) amino 
acids. Color coding from A applies. Adapted from Junge et al., 2004
 
Despite the extensive functional characterization of the Munc13/CaM interactions in 
STP phenomena, little is known about the actual mechanism of regulation of 
Munc13 proteins by CaM. More detailed insights into the structure of the 
CaM/Munc13 complex could provide a platform for the design of Munc13 variants 
with altered affinity to CaM which would be useful for the comprehensive analysis of 
the role of Munc13 proteins in synaptic transmission and plasticity. A major obstacle 
in obtaining such structural information is the size of the Munc13 proteins (200 - 250 
kDa) - a challenge for recombinant production and thus for NMR and crystallography 
approaches. In such cases, methodologies employing model peptides mimicking the 










1.6. Photoaffinity labeling  
1.6.1. General principles of photoaffinity labeling for structural analysis 
Photoaffinity labeling (PAL) emerged as a technique for the characterization of 
protein/ligand interactions more than four decades ago (Singh et al., 1962), but 
recent developments of more efficient photophores, new high resolution separation 
methods and detection techniques with higher sensitivity have led to renewed 
appreciation and applications of this methodology. The basic principles of PAL have 
remained essentially unchanged: ligands carrying photoreactive (but chemically 
inert) moieties are introduced into a system that includes a target protein interactor 
and are allowed to form ligand-protein complexes. UV light irradiation results in the 
formation of activated ligand intermediates that react with amino acids within the 
binding pocket of the target protein to form covalent photoadducts. These can be 
isolated and analyzed at the protein level, oligopeptide, and amino acid level, the 
latter providing the most comprehensive structural information (Fig. 7).  
 
 
Figure 7. Schematic representation of the main principles of a photoaffinity labeling (PAL) 
experiment. Photoactivation leads to the covalent attachment of a peptidic photoprobe carrying a 
photoreactive group (photophore) to a specific target protein. Thereby, a reversible non-covalent 
interaction is converted into a covalent complex, making it accessible for standard protein 
analytical techniques. Several levels of analysis can yield information about the structure of the 




At the protein level, detection of the intact photoadducts by gel electrophoresis - or 
more accurately by mass spectrometry - reveals the molecular weight of the 
complex and thereby information on its stoichiometry. Proteolytic digestion of the 
complex and subsequent chromatographic and mass spectrometric methods allows 
narrowing down the protein sequences that have participated in photoadduct 
formation and are thus part of the binding site of the protein. Sequencing of a 
photolabeled protein fragment (i.e. a cross-linked peptide) can ultimately lead to the 
identification of the exact site of photoincorporation at the amino acid level. For this 
purpose, mass spectrometry – rather than Edman degradation – is the method of 
choice, as it is very sensitive and, most importantly, allows sequencing from peptide 
mixtures. Thus, a single PAL experiment can provide valuable information about the 
stoichiometry of a peptide-protein interaction, and the location and architecture of 
the binding interface. 
 
1.6.2. Requirements of the photoreactive group 
An efficient photoreactive group should meet several requirements. The photophore 
should be sufficiently small so that, once incorporated into the ligand, it does not 
create any steric interference that may compromise the biopotency of the 
photoprobe. It is important to establish that the incorporated photoreactive group 
does not significantly alter the binding affinity and functionality of the photoprobe, 
compared to the nonderivatized ligand. The photophore should demonstrate 
reasonable chemical stability under ambient light. Its photochemically generated 
excited state should have a lifetime shorter than that of the ligand-target protein 
complex but sufficiently long for the photophore to remain in close proximity to the 
binding site and form a covalent bond within it. The photoreactive group should 
undergo unambiguous photochemistry that leads to the generation of a single 
covalent photoadduct. Finally, the photophore should preferentially attack C–H and 
nucleophilic X–H bonds at an activation wavelength longer than the UV absorption 
of most proteins (300 nm), in order to avoid photolytic damage. Under these 
conditions stable covalent complexes are formed that can survive more rigorous 
downstream structural analysis, such as electrophoresis, chromatography and mass 
spectrometry. 
The most common photophores currently employed in photoaffinity labeling studies 




1993; Vodovozova, 2007). The aryl azide and diazirine photoreactive groups are 
precursors of nitrene and carbene reactive species, while the benzophenone-based 
compounds rely on the photochemistry of aryl ketone intermediates (Dorman and 
Prestwich, 2000). Benzophenone photophores offer several advantages compared 
to their azide and diazirine counterparts in studies of protein complex structures and 
interactions. Benzophenone derivatives are generally more stable and may be 
manipulated in ambient light without significant degradation. Their activation takes 
place at 350 nm, a wavelength sufficiently high to avoid protein photolysis (Dorman 
and Prestwich, 1994). Furthermore, benzophenones retain stability in many common 
protic solvents and preferentially react with C–H bonds, even in the presence of 








The utility of p-Benzoyl-Phe (pBpa) was first demonstrated in the lab of William 
DeGrado where they incorporated this amino acid into a designed 17-residue 
peptide that interacted with, and efficiently labeled calmodulin (Kauer et al., 1986). In 
extension of this work they used fragmentation of the labeled protein, separation of 
the fragments by reverse-phase HPLC, and Edman degradation, and were able to 
identify the site of photolabel incorporation in calmodulin, which, depending on the 
position of the photoprobe within the peptide, was either Met71 or Met144 (O'Neil et 
al., 1989). In another early study, Miller and Kaiser used a pBpa-modified analogue 
of kemptide in similar interaction studies with cAMP-dependent protein kinase to 
identify Gly125 and Met127 of the enzyme as the sites of photoincorporation (Miller 
and Kaiser, 1988; see Dorman and Prestwich, 1994, for review of examples of site-
directed photoaffinity labeling with pBpa containing ligands). 
More recently, PAL techniques have been interfaced with modern mass 
spectrometry (MS) to yield greater efficiency and speed in providing additional 
structural and mechanistic information regarding protein complexes, such as the 




identification of the amino acid residues, which are involved in the ligand–receptor 
interaction (Girault et al., 1996; Jahn et al., 2002; Jahn et al., 2003; Mills et al., 
1998). This capacity to provide insights into the primary structure of interaction sites 
makes the integration of PAL and MS tools a powerful strategy for structure-based 
drug design (Dorman and Prestwich, 2000). 
PAL in combination with mass spectrometric characterization of the covalent 
photoadducts was used in the initial characterization of the conserved CaM binding 
sites in Munc13-1 and ubMunc13-2 (Junge et al., 2004). Using peptidic photoprobes 
covering the proposed CaM binding domains in Munc13-1 and ubMunc13-2 Junge 
and colleagues showed the specific, stoichiometric, and Ca
2+
-dependent binding of 
these Munc13 isoforms to CaM. 
 
 
1.7. Principles and applications of MALDI-TOF mass spectrometry 
Mass spectrometry (MS) is an analytical technique that measures the mass-to-
charge ratio (m/z) of ionized molecules in the gas phase as a function of their 
motility in an electric or magnetic field. Measurements are performed on a mass 
spectrometer, an instrument that consists of three main components: an ion source 
where the gas phase ions are produced from the sample molecules, a mass 
analyzer that measures the m/z of the ionized analytes, and a detector that registers 
the number of ions at each m/z value. 
Electrospray ionization (ESI) (Fenn et al., 1989) and matrix-assisted laser 
desorption/ionization (MALDI) (Karas and Hillenkamp, 1988) are by far the most 
important ionization techniques in bioanalytical MS. By ESI, the analytes are 
transferred from the liquid phase into the high-vacuum of the mass analyzer, leading 
mainly to multiply charged ions. It is therefore well suited for a direct on-line coupling 
with liquid-based chromatographic separation methods, most commonly reversed-
phase HPLC. By MALDI, in contrast, the analytes are transferred from the solid 
phase into the high-vacuum of the mass analyzer, leading mainly to singly charged 
ions. As a prerequisite, the analyte needs to be embedded into a crystalline UV light-
absorbing matrix, from which it can be desorbed via laser pulses. Due to the pulsed 
nature of MALDI, it has been predominantly coupled with the time-of-flight (TOF) 
analyzer - a pulsed analyzer that measures m/z ratios on the basis of the flight time 
of an ion, which, at a constant accelerating voltage, is proportional to the square root 




Two technical developments have contributed greatly to the high resolution and 
mass accuracy of the MALDI-TOF instruments. First, the delayed extraction of ions 
from the source ensured that a much tighter packet of ions arrives at the detector. 
Second, the incorporation of a reflector unit meant an increase in the effective length 
of the analyzer tube and thus the path of the ions, while it led to a reduction in the 
kinetic energy distribution of ions of the same mass, thereby causing their improved, 
time-focused arrival at the detector (Fig. 9) (see (Hillenkamp and Peter-Katalinic, 
2007) for technical details).  
                              A 
 
 
Figure. 9  MALDI-TOF-MS. (A) Schematic of a reflector MALDI-TOF mass spectrometer. In a 
MALDI time-of-flight (TOF) instrument, analytes are desorbed and ionized by a laser pulse. 
Following a delayed extraction (magnified inset), ions get accelerated to high kinetic energy and 
separated along a flight tube as a result of their different velocities. The ions are turned around in 
a reflector to compensate for slight differences in kinetic energy, and reach a detector that 
amplifies and counts arriving ions. (B) Chemical structure of a polypeptide showing the 
nomenclature for fragment ions (after Roepstorff–Fohlmann–Biemann) resulting from peptide 
fragmentation by collision-induced dissociation. Bond breakage occurs predominantly through the 
lowest energy pathways, i.e. cleavage of the amide bonds. This generates b-ions when the 
charge is retained by the amino-terminal fragment and y-ions when it is retained by the carboxyl-
terminal fragment. The major fragment ions of tryptic peptides observed in MALDI-TOF-MS are y 
> b >> a, and so only these are shown for the sake of clarity. Adapted from Aebersold and Mann, 





MALDI-TOF-MS provides high resolution, mass accuracy and sensitivity, while being 
robust, fast, and easy to automate, features making it well suited for the analysis of 
peptides in general. One of its most prominent applications is the identification of 
proteins by peptide-mass fingerprinting (PMF), a method based on the matching of a 
list of experimentally determined peptide masses with the calculated list of all 
peptide masses of each entry in a comprehensive protein database (Thiede et al., 
2005). More recently, straightforward peptide sequencing capabilities have been 
implemented into MALDI-TOF-MS, technically realized with the advent of TOF/TOF 
tandem mass analyzers (Suckau et al., 2003). In MALDI-TOF-MS-based 
sequencing, a particular peptide ion is isolated, and its fragmentation is induced 
through high-energy collisions with residual gas molecules or an inert collision gas. 
The resulting fragment ion mass spectra (commonly referred to as MS/MS spectra) 
represent amino acid sequence-specific fragment ions as products of randomized 
breakages at different bonds within the precursor peptide. The most abundant (and 
thus often most informative ions) are generated by fragmentation at the peptide 
backbone. They are called b-ions if the charge is retained by the N-terminal part of 
the peptide and y-ions if the charge is retained by the C-terminal part (Fig. 9) (Steen 
and Mann, 2004). These sequencing capabilities have not only added another level 
of confidence to protein identification by MALDI-TOF MS, but also allow for the 
detection and localization of post-translational and chemical modifications as well as 
cross-linking sites. 
Traditionally, MALDI-TOF MS has been preferred for the analysis of relatively simple 
peptide mixtures. However, it can be interfaced to an off-line liquid chromatography 
(LC) separation step to assay more complex samples. In such an LC-MALDI 
configuration peptides are eluted from an LC-column and directly spotted onto a 
MALDI target plate. In this way samples are available for comprehensive data 
acquisition and can even be archived for reconsideration, independent from the 
temporal constraints imposed by an on-line LC configuration. The chromatographic 
separation leads to a reduction in spectral complexity and circumvents the effects of 




1.8. Aims of this study 
Using the initial biochemical and functional annotation of the Munc13/CaM 
interactions (Junge et al., 2004) as a starting point, the work presented here was 
motivated by the following goals: 
 
• Establishment and biochemical characterization of non-conserved CaM 
domains in bMunc13-2 and Munc13-3 and generation of tools for elucidating 
the physiological features of these interactions. 
• Definition of the Ca
2+
 sensitivity of formation of the Munc13/CaM complex, 
• Establishment of a PAL-based analytical workflow for the structural 
characterization of peptide/protein interactions, 
• Implementation of this workflow for the structural analysis of the 
Munc13/CaM interaction, 
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2. MATERIALS AND METHODS 
2.1. Photoaffinity Labeling and Mass Spectrometry 
2.1.1. Prediction of CaM binding sites 
Due to the lack of a single consensus sequence for CaM binding sites across all 
Munc13 isoforms, the N-terminal sequences of bMunc13-2 (GenBank accession 
number U24071) and Munc13-3 (GenBank accession number U75361) were 
surveyed for similarities with a web-based CaM target database 
(http://calcium.uhnres.utoronto.ca/ctdb) (Yap et al., 2000). As these searches 
returned no hits, a bioinformatic prediction tool available on the same server was 
used to screen the Munc13 sequences for the presence of potential CaM recognition 
motifs. This program employs biophysical and structural criteria such as 
hydropathy,-helical propensity, residue size, residue charge, hydrophobic residue 
content, helical class, and occurrence of particular residues to determine putative 
CaM binding sites (Yap et al., 2000). Scores indicating the propensity of a residue to 
be part of a CaM binding site are evaluated for a sliding twenty-residue window and 
normalized to the entire sequence. 
 
2.1.2. Peptide synthesis 
All peptides and peptidic photoprobes (Table 1) were synthesized by solid phase 
peptide synthesis using standard fluorenylmethoxycarbonyl (Fmoc) chemistry as 
described (Jahn et al., 2002). The shorter peptides were N-terminally elongated by 
an artificial Cys residue to enable a selective coupling chemistry via the sulfhydryl 
group, an option for future experiments that was not used in the present study. 
Three types of peptides were synthesized: unmodified, ‘wild type’ peptides covering 
the predicted CaM binding sequences in each Munc13 isoform; CaM-insensitive 
peptides in which the proposed hydrophobic anchor residue (Trp or Phe) was 
substituted for Arg; and peptides carrying a p-Benzoyl-Phe photophore. Instead of 
modifying the Munc13-derived peptides N-terminally by a benzophenone group as 
performed previously (Junge et al., 2004), the photophore was directly introduced 
into the polypeptide chain by using the photoreactive amino acid derivative Fmoc-p-
Benzoyl-Phe (Bachem). Purified peptides were characterized by analytical reversed-
phase HPLC and mass spectrometry. Amino acid analysis was used to determine 
the exact concentrations of peptide stock solutions. 
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Table 1. Synthetic peptides used in this study. Numbering of amino acids refers to the rat 
sequences (GenBank accession numbers: Munc13-1, U24070; ubMunc13-2, AF159706; 
bMunc13-2, U24071; Munc13-3, U75361). Bp, benzophenone; f, p-Benzoyl-Phe. 
 
Nomenclature Sequence Origin 






-13-1    CRAKANfLRAFNKVRMQLQEAR 
R
464






























-ub13-2    CQARAHfFRAVTKVRLQLQEIS 
R
387
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2.1.3. Photoaffinity labeling (PAL) 
For the initial PAL experiments, 5 M salt-free bovine brain CaM (product number 
P2277, Sigma) and 5 M peptidic photoprobe were incubated for 2 h at room 
temperature under light exclusion in 250 mM ammonium acetate (pH 8) in the 
presence of 2 mM EGTA or 3 mM CaCl2. DTT (5 mM) was included to prevent 
intermolecular disulfide bond formation of the N-terminal Cys residues present in all 
peptides used. The exact concentrations of CaM stock solutions were determined by 
amino acid analysis. Activation of the photophore with UV light was performed on ice 
using an Ultratech 400 W halogen metal vapor lamp (Osram) and a B270 glass 
screen (Schott) to filter protein-damaging wavelengths below 300 nm (Jahn et al., 
2002). Unless stated otherwise, UV irradiation was carried out for 20 min. Following 
UV irradiation, photoadducts were separated from non-labeled CaM by denaturing 
SDS-PAGE on pre-cast NuPAGE 12 % Bis-Tris gels (Invitrogen) using a MOPS 
buffer system according to the manufacturer's instructions. Gels were fixed for one 
hour in ethanol/acetic acid and proteins were visualized using a colloidal Coomassie 
staining with Coomassie Brilliant Blue G-250 according to Neuhoff (Neuhoff et al., 
1988). 
The competition and cross competition reactions were carried out as above in the 
presence of increasing concentrations (0-50 M) of the wild-type or CaM-binding-
deficient control peptides as competitors. 
 
Buffer stocks: 
250 mM ammonium acetate, pH 8.0  
50 mM EGTA, pH 8.0 
50 mM CaCl2 
MOPS running buffer (20X): 1 M MOPS, 1 M Tris base, 20.5 mM EDTA, 2% SDS 
Fixing solution: 40% (v/v) ethanol, 10% (v/v) acetic acid 
Colloidal Coomassie dye stock solution: 0.1% (w/v) Coomassie Brilliant Blue G250, 2% 
(w/v) o-phosphoric acid, 10% (w/v) ammonium sulfate; activated with  parts of 100% 
methanol 
 
2.1.4. Detection of photoadducts by mass spectrometry 
For detection of photoadducts by matrix-assisted laser desorption/ionization (MALDI) 
time-of-flight (TOF) mass spectrometry, aliquots of the irradiated PAL reaction 
mixture were desalted on the basis of reversed-phase chromatography by using C18 
ZipTips (Millipore) according to the manufacturer's instructions. Sinapinic acid was 
used to prepare a matrix sandwich for the application of the samples on a ground 
steel sample support: a saturated sinapinic acid solution in ethanol was deposited 
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onto the sample position, which resulted in a microcrystalline matrix layer after 
evaporation of the solvent. Onto these precoated positions, 1 l of a premix 
consisting of equal volumes of the ZipTip eluate and of a saturated sinapinic acid 
solution (acetonitrile/0.1 % TFA, 1:2) was deposited and allowed to dry. After drying, 
the crystalline sample was washed once with 2 l 0.1 % TFA. A mixture of three 
standard proteins ranging from 12,360-23,981 Da (Protein Calibration Mix 2, 
LaserBio Labs) was prepared accordingly and used for external calibration. 
Positively charged ions in the mass-to-charge (m/z) range 5,000-30,000 were 
analyzed with a Bruker Ultraflex I MALDI-TOF mass spectrometer operated in the 
linear mode under the control of the FlexControl 2.4 operation software (Bruker 
Daltonics). Post-processing and calibration of the mass spectra was performed with 




 titration assay 
To investigate the Ca
2+
 sensitivity of the Munc13-CaM interaction, a PAL-based Ca
2+
 
titration assay was established. For that purpose, bovine brain CaM and peptidic 
photoprobe were incubated as described above for PAL, with the exception that a 
titration PAL buffer more closely resembling the presynaptic conditions was used. 
Defined concentrations of free Ca
2+
 were achieved by different Ca
2+
/chelator buffer 
systems. Maxchelator (http://www.stanford.edu/~cpatton/maxc.html), a program for 
determining the free metal concentration in the presence of chelators (Patton et al., 
2004) was used to calculate the Ca
2+
/chelator ratios needed to obtain the desired 
concentrations of free Ca
2+
. For free Ca
2+
 concentrations in the range of 1-1000 nM, 
10 mM EGTA was included into the titration buffer and 0.06-8.5 mM CaCl2 were 






/EGTA buffer composition for free Ca
2+






0 10 mM - 
1 nM 10 mM 0.057 mM 
3  nM 10 mM 1.68   mM 
10  nM 10 mM 0.54   mM 
20  nM 10 mM 1.03   mM 
30  nM 10 mM 1.46  mM 
50  nM 10 mM 2.22  mM 
100 nM 10 mM 3.63  mM 
300 nM 10 mM 6.31  mM 
1  M 10 mM 8.51  mM 
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Separation of the photoadducts from non-labeled CaM by SDS-PAGE and 
visualization of the proteins by colloidal Coomassie staining were performed as 
described above. 
Buffer stocks: 
PAL buffer: 10 mM HEPES 150 mM KCl, pH 7.2 
50 mM EGTA, pH 7.2 
50 mM CaCl2 
 
2.1.6. Documentation and quantification of SDS-PAGE gels 
All gels were documented with a near-infrared fluorescence imager (Odyssey 
system; LI-COR). Quantification of proteins was carried out on the basis of the 
Coomassie fluorescence that can be recorded in the 700 nm channel as this 
fluorescence is linearly correlated to the amount of Coomassie-stained protein in the 
concentration range used in this study (Luo et al., 2006).  
 
2.1.7. Determination of trace calcium 
Trace calcium in virtually calcium-free samples was determined by inductively 
coupled plasma mass spectrometry (ICP-MS) using a quadrupole instrument 
equipped with a dynamic reaction cell (ELAN DRC II, Perkin Elmer). Ammonia at a 
flow rate of 1 ml/min was used as reaction gas (Rpq = 0.5) to eliminate plasma-
















 to enable the quantification of trace calcium in the presence 




). The detection limit for calcium was 
approximately 20 ppb. Measurements were performed by Klaus Simon at the 
Department of Geochemistry, University of Göttingen. 
 
2.2. Structural analysis of photoadducts by LC-MALDI-MS 
2.2.1. Calmodulin 
Recombinant CaM and 
15
N-CaM were generated by Fernando Rodriguez-
Castañeda as described (Haberz et al., 2006). Transformed E. coli were grown in 
minimal medium containing NH4Cl or 
15
NH4Cl as nitrogen source. CaM was first 
enriched by a bulk purification step on the basis of TCA precipitation and further 
purified through hydrophobic interaction chromatography on a phenylsepharose 
column. Collected fractions were analyzed by SDS-PAGE. Recombinant CaM was 
compared with bovine brain CaM in the different PAL experiments described above 
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in order to examine its photoadduct yield, complex stoichiometry, and Ca
2+
 




The PAL experiments for the structural analysis were carried out in the presence of 
30 nM free Ca
2+
 under the quasi physiological conditions as described in Section 
2.1.5. As before, 5 M recombinant CaM and 5 M photoprobe were used. 
Equimolar solutions of 
15
N-CaM were prepared in the same buffer but in the 
absence of photoprobe, and handled in parallel. UV light irradiation was performed 
as described and equal volumes of the PAL sample and the 
15
N-CaM control sample 
were mixed. Photoadduct formation was monitored by denaturing SDS-PAGE and 
colloidal Coomassie staining as outlined above. MALDI-TOF-MS was used to co-
detect CaM, 
15
N-CaM, and the respective photoadducts at the level of intact 
proteins. 
 
2.2.3. HPLC/MALDI-TOF-MS for analysis of photoreaction mixtures 
The photoreaction mixtures were alkalized to pH 8.0 and directly subjected to in-
solution digest with recombinant porcine trypsin (Roche) for 16 hours (100 ng 
trypsin, 2 M urea, 10 % acetonitrile). The resulting mixtures of tryptic peptides were 
acidified with 1 l TFA and separated on a Dionex Hypersil C18 BDS column (0.3 x 
150 mm; particle size 3m, pore size 100 Å). The column was operated at a flow 
rate of 4 l/min using an ABI 140B syringe pump (Applied Biosystems) connected to 
an Accurate splitter (Dionex). Linear gradients formed by 0.1 % TFA and 0.1 % TFA 
containing 80 % acetonitrile were applied for elution. The separation was monitored 
by UV detection at 214 and 280 nm. Using a Probot microfraction collector (Dionex), 
30 s -fractions of the eluate were automatically spotted onto a Bruker 600/384 
AnchorChip target. Targets were pre-coated with a-cyano-4-hydroxycinnamic acid 
(HCCA) matrix as described (Jahn et al., 2006). To ensure uniform preparations 
independently of the eluent composition, the samples were re-crystallized with 
tetrahydrofurane:acetone:0.1%TFA = 7:2:1 (0.5 l/spot). All peptide survey and 
fragment ion mass spectra were recorded on a Bruker Ultraflex I MALDI-TOF/TOF 
mass spectrometer. Positively charged ions in the m/z range 500 to 5500 were 
analyzed automatically in the reflector mode under the control of the FlexControl 2.4 
operation software (Bruker Daltonics). Mass spectra were automatically post-
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processed with the FlexAnalysis 2.4 software (Bruker Daltonics) and then manually 
searched for candidate cross-linked peptides. Peptides of interest were selected as 
precursors for the manual acquisition of fragment ion spectra, which were annotated 
with the help of the BioTools 3.0 software (Bruker Daltonics). Relevant sample spots 
were subjected to on-target cyanogen bromide (CNBr) cleavage. 
For comparison with observed mass spectrometric data, theoretical isotope 




N-containing peptides were 
simulated with the MS-Isotope tool of the ProteinProspector program suite 
(http://prospector.ucsf.edu). This tool allows simulations with variable resolution and 
isotope content. 
 
2.2.4. Secondary proteolytic cleavage of exceptionally large cross-linked 
peptides with endoproteinase Asp-N 
In the cases when cross-linking with the Munc13-derived photoprobes took place 
within the largest tryptic CaM fragment CaM(38-74), the photoadducts were isolated 
by rpHPLC under the conditions described above, dried in a vacuum centrifuge, and 
subjected to in-solution digest with endoproteinase Asp-N (Pseudomonas fragi, 
Roche) for 16 hours (100 ng Asp-N, 25 mM Tris pH 8.0, 2 M urea, 10% acetonitrile). 
 
2.2.5. On-target CNBr cleavage of PAL-cross-linked peptides   
Spot positions containing candidate cross-linked peptides were treated on-target 
with CNBr to directly test whether a Met side chain was involved as site of 
photoincorporation into CaM (Kage et al., 1996). For that purpose, 2 l of a 
saturated CNBr solution in 70% (v/v) formic acid were applied onto the spot 
positions of interest. Spots were covered with small glass vials containing a filter 
paper soaked with the CNBr solution and the reaction was allowed to proceed over 
night at room temperature. After the reaction was terminated by evaporation of the 
CNBr solution, the target was directly introduced into the mass spectrometer. The 
corresponding peptide survey spectra were compared with those recorded before 
the CNBr cleavage and thereby screened for newly appearing signals corresponding 
to methylthiocyanate derivatives of the benzophenone-containing tryptic peptides 
derived from the photoprobes (monoisotopic mass shift +73.00 mass units, Fig. 10). 
The identity of such derivatives was confirmed by MS/MS sequencing. 




Figure 10. Mechanism of CNBr-induced ligand release of p-benzoyl-L-phenylalanine-
labeled photoadducts cross-linked at a Met residue. CNBr digest of Met-cross-linked 
photoadducts leads to release of the photoprobe with a mass increment of 73 mass units. 
Adapted from (Kage et al., 1996). 
 
 
2.3. Molecular Biology 
2.3.1. Materials 
2.3.1.1. Bacterial strains 
E. coli, XL-1 Blue competent cells (Stratagene) 
E. coli, ElectroTen-Blue competent cells (Stratagene) 
E. coli, BL21DE3 competent cells (Stratagene) 
 
2.3.1.2. Vectors 
pGEX-4T-1 (GE Healthcare Life Sciences) 
pCR2.1-TOPO (Invitrogen) 
pBlueScript II KS (-) (Fermentas) 
 
2.3.1.3. Plasmids 
pEGFP-N1-bMunc13-2 (provided by Prof. Nils Brose) 
pEGFP-N1-Munc13-3 (provided by Prof. Nils Brose) 
pVENUS-VGLUT (provided by Dr. Etienne Herzog) 
pGEX-Munc13-1(309-567) (provided by Dr. Andrea Betz) 
pGEX-bMunc13-2(366-780) (as generated in this study) 
pGEX-bMunc13-2(366-780)F580R (as generated in this study) 
pGEX-bMunc13-2(366-780)F723R (as generated in this study) 
pGEX-bMunc13-2(366-780)F580R/F723R (as generated in this study) 
pGEX-bMunc13-2(366-780)F723R/K724E/K728E/R731E (as generated in this study) 
pGEX-Munc13-3(711-1063) (as generated in this study) 
pGEX-Munc13-3(711-1063)F787R (as generated in this study) 
pGEX-Munc13-3(711-1063)F962R (as generated in this study) 
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pGEX-Munc13-3(711-1063)F787R/F962R (as generated in this study) 
pVENUS-N1-bMunc13-2 (as generated in this study) 
pVENUS-N1-bMunc13-2 F723R/K724E/K728E/R731E (as generated in this study) 
pVENUS-N1-Munc13-3 (as generated in this study) 
pVENUS-N1-Munc13-3 F962R (as generated in this study) 
 
2.3.1.4. Oligonucleotides 
Table 3. Synthetic oligonucleotides used in this study (synthesis done in the MPI-EM DNA 





12135 5'-GCGCGAATTCCATCAAGGGCTTAGTTTCCTACCAAAG -3' EcoRI 
12136 5'-CGCGATCTCGAGCTACCCTTCTGGGAGCCACTGAGG -3' XhoI 
12141 5'-CGCGAATTCTCTCCATGCCCTGGATTGGATAATG -3' EcoRI 
12142 5'-CGCGTACTCGAGCTAGTTCAGGGATGTCCTGATAACCATAGC -3' XhoI 
12412 5'-CGATCCACCACCGCCGTTTGGCTCTTCAG -3' - 
12413 5'-CTGAAGAGCCAAACGGCGGTGGTGGATCG -3' - 
12414 5'-CCTTAACAAATGCATCAACAATCGTAAAAACGTCCTAAGAG -3' - 
12415 5'-CTCTTAGGACGTTTTTACGATTGTTGATGCATTTGTTAAGG -3' - 
12416 5'-CCTTTAAGTTCCCCAAACGTGGATCCACTCTTCAGAGG -3' BamHI 
12417 5'-CCTCTGAAGAGTGGATCCACGTTTGGGGAACTTAAAGG -3' BamHI 
12418 5'-GAGAATCCGACCTTCCCGCAAAGAAGCAGCTTTAAGG -3' - 
12419 5'-CCTTAAAGCTGCTTCTTTGCGGGAAGGTCGGATTCTC -3' - 
13357 5'-GCATCAACAATCGTGAAAACGTCCTAGAAGAGAAAGAGCTGAGGCAGAAAAAAC-3' - 
13358 5'-GTTTTTTCTGCCTCAGCTCTTTCTCTTCTAGGACGTTTTCACGATTGTTGATGC-3' - 
13731 5'-GCTAGAAAACAGGACTAGTGTGACTGAAGTAG -3' SpeI 
13732 5'-GCTTCTTTTCGCGAAGGTCGGATTCTCTTTGG -3' - 
13733 5'-CCAAAGAGAATCCGACCTTCGCGAAAAGAAGC -3' - 
13911 5'-CAGGGACACCCGGGCACATGTACTTAGAAGAC -3' SmaI 
13940 5'-GCAGATATGCGTGAAGGATTACTGC -3' - 











2.3.2.1. Electroporation of plasmid DNA into competent bacteria 
An aliquot (40 μl) of electrocompetent E.coli of the appropriate strain was let thaw on 
ice and 20 ng of plasmid DNA or 1 l of a ligation reaction were added, mixed gently 
and incubated for one minute on ice in a pre-cooled electroporation cuvette (0.1 cm, 
BioRad). The cuvette was administered an electric pulse of 1.80 kV (E.coli pulser, 
BioRad). Immediately following the electroporation the bacterial cells were retrieved 
from the cuvette with 0.8 ml pre-warmed Luria-Bertani (LB) Medium and allowed to 
recover and express their antibiotic resistance for 1 hour at 37°C under moderate 
shaking. For plasmid DNA electroporation 5-10 l of bacteria were plated on the 
appropriate selection plates; in case of ligation reactions, the bacteria were carefully 
centrifuged and the entire pellet was resuspended in 100 l LB Medium and plated 
on the appropriate selection plates. 
Buffer stocks and materials: 
LB Medium, per liter Millipore water: 10 g NaCl, 10 g Bacto-Tryptone, 5 g Bacto-
yeast extract, 100 l NaOH (10N stock); autoclaved 
LB plates: 15 g Bacto-agar per 1 l LB medium; autoclaved. Required selection 
antibiotic added before plates are poured. 
 
2.3.2.2. Small scale plasmid-DNA preparation 
Small amounts of plasmid DNA were isolated from 1,5 ml overnight bacterial culture 
using the PureLinkTM Quick Plasmid Miniprep Kit (Invitrogen) following the protocol 
supplied by the manufacturer or by the lysozyme-boiling method (Holmes and 
Quigley, 1981) as a rapid screening tool for ligation and/or transformation efficiency. 
According to this method the bacterial culture was pelleted for 30 s at 16,000 xg and 
resuspended in 300 l STET buffer. After addition of 250 g of lysozyme the 
suspension was boiled for 1 min at 100°C (water bath) and centrifuged for 10 min at 
16,000 xg. The cell debris/protein pellet was removed with a toothpick and 100 ml of 
ammonium acetate (7.5 M) and 400 l of isopropanol (100 %) were added to the 
supernatant. The sample was mixed and centrifuged immediately for 30 min at 
16,000 xg. The pellet was let to air-dry and resuspended in 50 ml TE buffer for 30 
min at 37°C upon mild shaking. 
Buffer stocks: 
STET: 8% sucrose, 0.5% Triton X-100, 10 mM Tris-HCl pH 8.0, 50 mM EDTA 
Lysozyme:10 mg/ml in Millipore water 
7.5 M ammonium acetate 
TE buffer: 10mM Tris-HCl pH 7.4, 1mM EDTA  
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2.3.2.3. Medium scale plasmid DNA preparation 
For midi preparations of Plasmid DNA, a 100 ml bacterial culture was grown 
overnight. The DNA preparation was carried out using the PureLinkTM Quick Plasmid 
Midiprep Kit (Invitrogen) following the protocol supplied by the manufacturer. The 
DNA pellet was redissolved in 100 μl TE buffer at 37°C. 
 
2.3.2.4. Determination of DNA concentration 
For the determination of the DNA concentration of aqueous solutions, a Genesys 6 
Spectrophotometer (Thermo Spectronic) was used for absorption measurement at 
260 nm wavelength (for double-stranded DNA 1 OD260 = 50 mg/ml). 
 
2.3.2.5. Sequencing of DNA 
All DNA sequence analysis was done in the MPI-EM DNA Core Facility on an 
Applied Biosystems 373 DNA Sequencer.  
 
2.3.2.6. DNA digest with restriction endonucleases 
Analytical and preparative DNA digests were carried out for screening/sequence 
confirmation purposes and for the use of the DNA fragments in further subcloning 
steps. Instructions in the New England Biolabs manual were followed for the 
appropriate restriction endonuclease/buffer combination and overall reaction 
conditions. Generally digests were performed for 1.5 – 3 hrs at the enzyme specific 
temperature. When a consecutive digest with a second restriction enzyme was 
required, reactions were precleaned using the Invisorb® MSB spin PCRapace kit 
(Invitek). 
 
2.3.2.7. Dephosphorylation of 5´DNA-ends  
Dephosphorylation of the 5´-ends of DNA plasmids cut with a single restriction 
endonuclease was carried out in order to prevent recircularization of vectors in 
further DNA ligation reactions. The plasmid DNA was treated with alkaline 
phosphatase (calf intestine, Roche) in the supplied buffer according to 
manufacturer’s instructions. Before further use, the DNA was purified by extraction 
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2.3.2.8. Refilling of cohesive 5´DNA fragment ends 
For the fill-in of the 5´ overhangs of DNA fragments to be ligated into blunt-end 
vectors Pfu DNA polymerase (Stratagene) or the Klenow fragment of DNA 
polymerase I (New England Biolabs) were used. For refilling with Pfu the precleaned 
DNA fragment was supplemented with dNTPs, Pfu buffer and the Pfu DNA 
polymerase in a total of 100 l and incubated for 1 hour at 72ºC. For refilling with 
Klenow the precleaned DNA fragment was supplemented with dNTPs, the supplied 
buffer and the Klenow fragment and incubated for 20 min at room temperature. In 
both cases the DNA was extracted with phenolchloroform before further use (see 
below). 
 
2.3.2.9. DNA Ligation 
For ligation, digested plasmid and insert with compatible ends were mixed in a molar 
ratio of 1:4 and supplemented with T4 DNA ligase (Invitrogen) and the ligase-
specific buffer in a total of 20l reaction volume. The ligation reaction was allowed to 
proceed for 16-20 hours at 16ºC. Before electroporation into competent bacteria, the 
DNA was precipitated with ethanol (see below). 
 
2.3.2.10. Ethanol precipitation of DNA 
In order to increase the DNA concentration available for the electroporation of 
ligation products the ligation reaction (20 l) was supplemented with 2 l of kalium 
acetate (3 M) and 60 l ethanol (100 %) and placed at -80ºC for 2 hours. The 
precipitate was pelleted for 30 min at 16,000 xg in a pre-cooled bench-top 
centrifuge, the pellet was washed with 70 % ethanol and resuspended in 5 l 
distilled water. 
Buffer stocks: 
3 M kalium acetate (10X) 
 
2.3.2.11. Phenolchloroform extraction 
Phenolchloroform extraction was performed on DNA samples following 
dephosphorylation or fill-in reactions in order to remove any enzymes and impurities 
that could compromise DNA ligation efficiency. For that purpose the DNA sample 
was dissolved in a total of 300 l Millipore water, 300 l of phenol were added and 
the mixture was vortexed thoroughly until turbid. The mixture was centrifuged for 3 
min at 16,000 xg to achieve phase separation. The upper aqueous phase was 
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transferred to a clean vial, 300 l of phenolchloroform (1:1) were added and the 
mixture was vortexed thoroughly. Following a centrifugation step the upper aqueous 
phase was transferred to a clean vial and washed twice with 300 l chloroform as 
described above to remove all phenol. The DNA in the aqueous phase was 
precipitated with ethanol and kalium acetate (see above). 
 
2.3.2.12. Agarose gel electrophoresis 
For the analysis or purification of DNA restriction fragments the reactions were 
subjected to agarose-gel electrophoresis on 0.7 - 2 % agarose gels in TBE buffer 
including ethidium bromide (Roth). The negatively charged DNA fragments were 
separated at constant voltage (80-120 V) in TBE buffer and visualized by ethidium 
bromide under UV-light (254 or 314 nm). DNA fragment sizes were estimated by a 
GeneRuler DNA Ladder Mix sample (Fermentas) run on the gel in parallel. 
Buffer stocks: 
TBE running buffer (10X): 0.5 M Tris-Base, 0.5 M boric acid, 20 mM EDTA, pH 
8.0 
Ethidium bromide (2000X): 10 mg/ml 
 
2.3.2.13. Agarose gel extraction of DNA fragments 
DNA fragments of interest were excised and isolated from agarose gel with the 
PureLink
TM
 Quick gel extraction kit (Invitrogen) according to the protocol supplied by 
the manufacturer. 
 
2.3.2.14. Polymerase Chain Reaction (PCR) 
Amplification of DNA in vitro was carried out by PCR. The reaction included double-
stranded DNA template, oligonucleotide primers, dNTPs, the high-fidelity Pfu DNA 
polymerase (Stratagene) and the supplied buffer. All PCR reactions were run on 
Gene Amp 9700 PCR cycler (Applied Biosystems) with the basic cycle parameters 
as follows: 
Step 1:  94°C for 3 min 
Step 2:  94°C for 20 s 
Step 3:  Annealing temperature for 30 s 
Step 4:  72°C for extension time (30-40 cycles from step 2) 
Step 5:  72°C for 10 min 
Annealing temperatures were chosen at 5°C lower than the mean calculated melting 
temperature of the primers used in the reaction; extension time was adjusted 
according to the length of the PCR product. PCR products to be used in subcloning 
reactions were purified with the Invisorb
®
 MSB spin PCRapace kit (Invitek). 
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2.3.2.15. Subcloning in TOPO pCR ® 2.1 vectors 
The TOPO® TA cloning Kit (Invitrogen) was used for the rapid subcloning of PCR 
products. Protocols supplied by manufacturer were closely followed. 
 
2.3.2.16. Cloning strategies for constructs generated and used in this study 
pGEX-bMunc13-2(366-780) 
Primers 12135/12136 were used on a pEGFP-N1-bMunc13-2 template for PCR 
amplification of a 1264 bp long fragment corresponding to amino acids 366-780 in 
bMunc13-2 from Rattus Norvegicus (GenBank accession number U24071). The 
fragment was directly subcloned in pCR2.1TOPO, further excised with EcoRI/XhoI 




Primers 121341/12142 were used on a pEGFP-N1-Munc13-3 template for PCR 
amplification of a 1080 bp long nucleotide fragment corresponding to amino acids 
711-1063 in Munc13-3 from Rattus Norvegicus (GenBank accession number 
U75361). The fragment was directly subcloned in pCR2.1TOPO, further excised with 
EcoRI/XhoI (restriction sites introduced via the primers) and ligated into the 
corresponding sites of pGEX-4T1. 
 
pVENUS-N1-bMunc13-2 
The VENUS cassette was excised from pVENUS-VGLUT with AgeI/NotI and ligated 
in the same restriction sites on pEGFP-N1-bMunc13-2, replacing EGFP. Primer 
13940 was designed for the sequencing confirmation of the in-frame position of the 
VENUS cassette N-terminally of bMunc13-2. 
 
pVENUS-N1-bMunc13-2 F723R/K724E/K728E/R731E 
PstI and NotI were used to excise a 1.2 kb fragment from pGEX-bMunc13-2(366-
780)F723R/K724E/K728E/R731E containing the CaM-insensitive mutated sequence 
and the fragment was subcloned into the corresponding restriction sites of 
pBluescript II KS (-), giving rise to pBluescript II KS –bMunc13-2-T1. A 2 kb fragment 
containing the 5’- end of bMunc13-2 was excised with EcoRI and PstI from 
pVENUS-N1-bMunc13-2 and subcloned into the corresponding restriction sites of 
the pBluescript II KS –bMunc13-2-T1, giving rise to pBluescript II KS –bMunc13-2-
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T2. SpeI and BstEII were used to excise a 2.1 kb fragment from pBluescript II KS –
bMunc13-2-T2 covering the CaM-insensitive mutation sequence and inserted it into 




The VENUS cassette was excised from pVENUS-VGLUT with AgeI/NotI and ligated 
in the same restriction sites on pEGFP-N1-Munc13-3, replacing EGFP. Primer 
13941 was designed for the sequencing confirmation of the in-frame position of the 
VENUS cassette N-terminally of Munc13-3. 
 
pVENUS-N1-Munc13-3 F962R 
Primers 13731/12732 were used for directed mutagenesis and PCR amplification of 
a 250 bp fragment from pVENUS-N1-Munc13-3 that contains a 5’- Spe I restriction 
site and the F962R CaM binding mutation. Primers 13733/13911 were used for the 
site-directed mutagenesis and PCR amplification of a 1.4 kb fragment from 
pVENUS-N1-Munc13-3 that contains the F962R CaM binding mutation and a 3’- 
Sma I restriction site. The two fragments were used in a fill-in PCR reaction, giving 
rise to a 1.6 kb fragment which was subcloned into pCRII-TOPO. This construct was 
digested with SpeI and SmaI and the resulting 1.6 kb fragment was ligated into the 
same restriction sites of pVENUS-N1-Munc13-3, giving rise to pVENUS-N1-Munc13-
3 F962R. 
 
2.3.2.17. Site-directed mutagenesis 
The following plasmids containing Munc13 constructs with mutations as specified 
were generated using a QuikChange® Site-Directed Mutagenesis Kit (Invitrogen) 
under conditions suggested in the manufacturer’s manual. Numbering of the primers 
used for the site-directed mutagenesis refers to Table 3.  
 
- pGEX-bMunc13-2(366-780)F580R, primers 12412/12413  
- pGEX-bMunc13-2(366-780)F723R, primers 12414/12415  
- pGEX-bMunc13-2(366-780)F580R/F723R, primers 12414/12415 on template 
pGEX-bMunc13-2(366-780)F580R 
- pGEX-bMunc13-2(366-780)F723R/K724E/K728E/R731E, primers 
13357/13358 on template pGEX-bMunc13-2(366-780)F723R  
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- pGEX-Munc13-3(711-1063)F787R, primers 12416/12417  
- pGEX-Munc13-3(711-1063)F962R, primers 12418/12419  




2.4. Co-sedimentation assays 
2.4.1 Expression of GST-fusion proteins 
The GST Gene Fusion System (GE Healthcare Life Sciences) was used for the 
bacterial expression of GST-fused bMunc13-2 and Munc13-3 fragments. pGex-4T-1 
plasmids carrying different constructs were transformed  by electroporation into  E. 
coli of the BL21DE3 strain. Single colonies were transferred into 5 ml of LB medium 
supplied with ampicillin (100 l/ml) and incubated with vigorous shaking overnight at 
37°C. This preculture was diluted in 50 ml of LB medium supplied with ampicillin and 
incubated further at 37°C until the optical density of the culture at 600 nm reached 
~0.85. The bacterial culture was let to cool down to room temperature, 0.1 mM 
isopropyl -D-1-thiogalactopyranoside (IPTG) was added for the induction of protein 
expression and the culture was shaken for 2 hours at room temperature. The 
bacteria were sedimented for 20 min by centrifugation (4500 xg, 4°C) and the pellet 
was washed with 5 ml PBS and resuspended in buffer A supplied with the protease 
inhibitors 0.1 mM PMSF, 0.1 mM aprotinin, 0.1 mM leupeptin and 0.1 mM DTT. The 
cells were lysed by sonification using the Macro-tip from the Labsonic U Sonifiers 
(Braun) (5 pulses x 10 seconds). Triton X-100 (0.1%) was added to the suspension 
to solubilize the protein and it was shaken for 20 minutes on ice. The cell debri were 
pelleted by ultracentrifugation (100,000 xg, 30 minutes, 4°C) and the clear 
supernatant containing the soluble GST-fusion proteins was filtrated through a 
sterile 0.22 m Millipore filter.  
 
2.4.2. CaM co-sedimentation assay 
Glutathione sepharose 4B beads were prepared as outlined in the GST Gene 
Fusion System handbook (GE Healthcare Life Sciences) and were incubated 
overnight at 4°C with the filtrated bacterial supernatant to allow adsorption of the 
GST-fusion proteins. The beads were washed 4 times with buffer A containing 
protease inhibitors and DTT, then equilibrated with either buffer E or buffer C and 
incubated with 30 ng/l of CaM (bovine brain, Roche) in the respective buffers for 4 
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hours at 4°C. The beads were washed 3 times with either buffer E or buffer C, boiled 
for 3 min in SDS sample buffer and analyzed by denaturing SDS PAGE on pre-cast 
NuPAGE 12 % Bis-Tris gels (Invitrogen) using a MOPS buffer system according to 
the manufacturer's instructions.  
The Coomassie fluorescence signals from the bands corresponding to the GST-
fusion proteins (apparent molecular weight ~65 kDa) and the CaM co-sedimented 
under each condition (apparent molecular weight ~17 kDa) were quantified based on 
2 independent experiments, and the signal-intensity/kDa values were used for the 
estimation of the stoichiometry of the interactions. 
 
Buffer stocks: 
0.5 M IPTG (500X) 
10% Triton X-100 
PBS (10X) 
Buffer A (2X): 40 mM Tris/HCl, pH 7.5; 300 mM NaCl, 2 mM EDTA 
Buffer E (2X): 100 mM Tris/HCl, pH 7.5; 300 mM NaCl; 2 mM EDTA; 
Buffer C (2X): 100 mM Tris/HCl, pH 7.5; 300 mM NaCl; 2 mM EDTA; 8 mM 
CaCl2 
CaM, bovine brain: 1 mg/ml in 10 mM HEPES, pH 7.5 
SDS sample buffer (3X): (163 mM Tris/HCl pH 6.8, 26% glycerol, 6% SDS, 
0.03% bromophenol blue, 13% -mercaptoethanol) 
1.5 M DTT 
100 mM PMSF (1000X) 
100 mM aprotinin (1000X) 





3.1. Characterization of the CaM interactions of bMunc13-2 and Munc13-3 
3.1.1. Screening for CaM binding sites in bMunc13-2 and Munc13-3 
The Munc13 isoforms bMunc13-2 and Munc13-1 do not contain a conserved CaM 
binding site with sequence homology to those found in Munc13-1 and ubMunc13-2. 
The first indication of the presence of a non-conserved CaM recognition motif in 
bMunc13-2 was provided by co-sedimentation experiments using GST-fusion 
proteins of bMunc13-2 fragments; these experiments identified bMunc13-2(627-755) 
as a minimal CaM-binding sequence (A. Betz and N. Brose, unpublished data). This 
amino acid sequence was therefore used as input for the web-based bioinformatic 
CaM-recognition-motif prediction tool available at the CaM target database 
(http://calcium.uhnres.utoronto.ca/ctdb). Based on this prediction amino acids 719-
742 of bMunc13-2 were identified as a potential CaM binding site (black dotted bar, 
Fig. 11). Although unrelated in amino acid sequence, this site corresponded to the 
established CaM binding sites Munc13-1(459-479) and ubMunc13-2 (382-402), with 
respect to its distance from the C1 domain (Fig. 11). Surprisingly, when the input for 
the prediction algorithm was extended to encompass the 500 amino acids N-
terminally of the C1 domain in bMunc13-2, a second sequence with high propensity 
for CaM binding was identified (amino acids 573-592, white dotted bar, Fig. 11). 
 
 
Figure 11. Established and potential CaM binding sites in the Munc13 proteins. Established 
conserved CaM binding sites in Munc13-1 and ubMunc13-2 are represented by black bars. 
Bioinformatically predicted non-conserved CaM binding sites in bMunc13-2 and Munc13-3 are 
represented by dotted and hatched bars, respectively. See Fig. 2 for details on the domain 
structure of Munc13. 
 
Analysis of the corresponding part of Munc13-3 (500 amino acids N-terminal of the 
C1 domain) with the prediction algorithm also revealed two potential CaM binding 
sites in this isoform. The positions of the two sites, comprising amino acids 786-804 




11). When the corresponding sequences of Munc13-1 and ubMunc13-2 were used 
as input for the prediction algorithm, no additional CaM binding sites were identified. 
 
 
3.1.2. Peptide design  
On the basis of the bioinformatic screening, four novel model peptides were 
synthesized covering the potential CaM binding sites of bMunc13-2 and Munc13-3. 
The potential CaM binding peptides, bMunc13-2(572-594) (b13-2a), Munc13-3(786-
804) (13-3a), bMunc13-2(719-742) (b13-2b), and Munc13-3(961-980) (13-3b) were 
synthesized and used in parallel with the previously characterized CaM binding 
peptides Munc13-1(459-479) (13-1) and ubMunc13-2(382-402) (ub13-2). All six 
CaM recognition motifs are at least related to the Ca
2+
-dependent 1-5-10 or 1-8-14 
motifs, and are therefore characterized by a hydrophobic anchor residue in position 
1 of the motifs (Chin and Means, 2000) (Trp in 13-1 and ub13-2, and Phe in b13-
2a/b and 13-3a/b).  
For the application of these Munc13-derived model peptides in PAL, the anchor 
residues were replaced with the photoreactive amino acid derivative p-Benzoyl-Phe 













-13-3b (Fig. 12). By 
applying this strategy, the photophore was directly introduced into the CaM binding 
site without changing the hydrophobic, bulky, and aromatic characteristics of the 
corresponding anchor position, thus minimizing interference with CaM binding. In 
addition to the wild-type peptides and their corresponding photoprobes, binding-
deficient homologs were synthesized based on the finding that Trp/Arg mutations 
within the CaM binding site abolish CaM binding of Munc13-1 and ubMunc13-2 
(Junge et al., 2004). To test whether this mutation effect is also seen at the peptide 
level and, if so, to verify it for bMunc13-2 and Munc13-3, we replaced the 























Figure 12. (A) Amino acid sequences of the model peptides covering the CaM binding 
sites of the different Munc13 isoforms. The sequences of the wild-type peptides are shown 
with the proposed hydrophobic anchor residue in red. The full names including the amino acid 
numbering and the abbreviations used throughout the text are given to the left and right of the 
sequences, respectively. The corresponding photoprobes and binding-deficient controls were 
generated by replacement of the anchor residue by p-Benzoyl-Phe (Bpa) and Arg (R), 
respectively. The Munc13-1- and ubMunc13-2-derived peptides display a high homology (59 % 
identity, identical residues are boxed), whereas the other sequences are unrelated. (B) 
Structures of Bpa (photoreactive residue), Trp/Phe (hydrophobic anchor residue), and Arg 
(substitution in binding deficient controls). Based on structural similarity the Bpa exchange 
was considered conservative. 
 
 














-13-3b were used in PAL experiments followed by gel-electrophoretic analysis 
of the photoreaction products to demonstrate the Ca
2+
-dependent CaM binding of 
the novel Munc13-derived photoprobes. First, photoadduct formation of the 





-ub13-2 (Junge et al., 2004), was compared with that 





-ub13-2. SDS-PAGE and colloidal Coomassie staining 
showed that the intensity of the Ca
2+
-dependent 20 kDa species corresponding to 









-ub13-2 (Fig.13A). Thus, the photoadduct yields were independent of 
the position of the photophore in the peptide, indicating that the photoprobes 
retained their affinity for CaM even after substitution of the anchor residue by p-












-ub13-2 (Fig. 13A). 
This can be explained by a greater flexibility of the benzophenone group at the N-
terminus of the peptides and its potential to cross-link CaM in different positions, 






Figure 13. Detection of CaM and its photoadducts by SDS PAGE and mass spectrometry.  













-13-3b in the 
absence (-) and presence (+) of Ca
2+





ub13-2, which were used previously to study CaM binding of Munc13-1 and ubMunc13-2 (Junge 
et al., 2004), were included for comparison. (B-I) Mass spectra showing, that all photoadducts 
were in principle represented by single signals corresponding to 1:1 species, even if a 
heterogeneous pattern was observed in the SDS gel. Only the mass spectra obtained from the 
PAL reactions in the presence of Ca
2+
 are displayed. Mass spectra were acquired by MALDI-TOF 
mass spectrometry using sinapinic acid as matrix. The mass increment of m/z = 206 detected for 
all signals was due to the known photochemically generated adducts of sinapinic acid. The 
calculated masses (Mcalc) of CaM and its respective photoadducts were as follows: Mcalc(CaM) = 
16790.4 (B-I), Mcalc(CaM+Bp
N
-13-1) = 19687.8 (B), Mcalc(CaM+Bp
N
-ub13-2) = 19638.7 (C), 
Mcalc(CaM+Bpa
464
-13-1) = 19544.7 (D), Mcalc(CaM+ Bpa
387
-ub13-2) = 19495.6 (E), Mcalc(CaM+ 
Bpa
580
-b13-2a) = 19716.8 (F), Mcalc(CaM+ Bpa
787
-13-3a) = 19159.2 (G), Mcalc(CaM+ Bpa
723
-b13-
2b) = 19877.1 (H), Mcalc(CaM+ Bpa
962
-13-3b) = 19367.4 (I). The maximal mass deviation was 
only 300 ppm. 
 
 
In order to investigate whether the predicted CaM binding sites in bMunc13-2 and 









-13-3b, and the photoreaction products 
analyzed as before. Similar to Munc13-1 and ubMunc13-2, Ca
2+
-dependent 20 kDa 
photoadducts species were detected for all four photoprobes employed (Fig. 13A), 
confirming the presence of two CaM binding sites in bMunc13-2 and Munc13-3, 





were not as homogenous as those of the other photoprobes, but rather appeared as 





-13-3a, which in turn would result in the 
formation of two defined photoadducts with different electrophoretic mobilities. Mass 
spectrometric analysis was used to determine whether these double-bands 
correspond to isomeric 1:1 photoadducts or to photoadducts of higher stoichiometric 



















signals corresponding to a 1:2 stoichiometry were observed, but only with intensities 
close to the detection limit (Fig. 13B, D, F, H, I). The presence of these minor signals 
was in agreement with the Ca
2+
-dependent 25 kDa species observed as faint 
smeary bands after gel-electrophoretic analysis of the respective photoreaction 




artifacts probably due to the very high Ca
2+
-concentrations and/or the relatively long 









-independent CaM binding capacity (Fig. 13A), which was not 
seen with full-length Munc13 proteins and was therefore considered as artifact due 
to protein truncation (Junge et al., 2004). Taken together, these initial PAL 
experiments demonstrated that all four Munc13-isoforms bind CaM in a Ca
2+
-
dependent manner and with a 1:1 stoichiometry. 
 
 
3.1.4. Specificity of photoadduct formation  
Competition experiments were employed in order to investigate the specificity of the 
synthetic photoprobes in their interactions with CaM. For that purpose increasing 
concentrations of the corresponding wild-type parent peptides were included into the 
PAL reaction, and the photoadduct formation was analyzed by gel electrophoresis 





-ub13-2, respectively, photoadduct formation was 
suppressed already at equimolar levels (Fig. 14A, B), indicating that photoreactive 
and unmodified forms of the peptides bind with similar affinity to the same binding 
site. Up to ten-fold higher concentrations of b13-2a and 13-3a, respectively, were 









-13-3b (Fig. 14C, D, E, F) indicating that these 
photoprobes exhibit increased binding affinities rather than that the photoreactive 
and unmodified forms use different binding sites. It has been previously reported 
that amphipatic model peptides exhibit an increased affinity for CaM upon 
incorporation of a Trp residue into the N-terminal part of the motif (O'Neil et al., 
1989), indicating a correlation between the affinity of these peptides to CaM and the 
bulkiness and hydrophobicity of their anchor residues. Accordingly, the replacement 




-ub13-2, (Fig. 13A) 
did not significantly alter the biophysical characteristics of the anchor positions, and 
therefore resulted in similar affinities of the photoreactive and unmodified forms. In 









-13-3b rendered the anchor position more 
hydrophobic, bulky, and aromatic, which equipped the photoprobes with higher 




On the basis of the data from the competition experiments, it was concluded that 
each of the four Munc13-derived photoprobes and their respective wild-type 
counterparts target the same binding site on CaM. In comparison to the wild type 
peptides, the affinity of the photoprobes was not decreased upon incorporation of 
the photophore, indicating an identical binding mode and suitability for later PAL-

















13-3a (E) and Bpa
962
-13-3b (F) in the absence (0 M), equimolar presence (5 M) and excess 
presence (50 M) of their respective unlabeled peptide homologs. Absence (-) and presence (+) 
of Ca
2+
 is indicated. Competition experiments in the presence of 50 M of the respective binding 






The competition approach was also used to test whether model peptides containing 
an Arg instead of the hydrophobic anchor residue were devoid of CaM binding, as 














3b were synthesized as binding-deficient homologs and used as competitors in PAL 




-ub13-2 to suppress 




-ub13-2 was considerably lower 
than that of the wild-type peptides (Fig. 14A, B). This effect of decreased affinity to 
CaM upon incorporation of Arg in position of the anchor residue held true - at least 
as a trend - for all binding-deficient homologs (Fig. 14). Taken together, the data 
from the competition experiments confirmed the essential role of the anchor residue 
for CaM binding of b13-2a/b and 13-3a/b, as well. This information, together with the 
knowledge that two CaM binding sites are present in bMunc13-2 and Munc13-3, 
respectively, was later used for the generation of CaM-insensitive variants of these 




 sensitivity of photoadduct formation 
Due to the established role of the CaM/Munc13 interaction in STP processes in 
response to elevations in residual Ca
2+
 at the presynapse, it was of interest to 
establish the Ca
2+
 concentrations required to trigger the CaM/Munc13 association. 
This question was addressed using the Munc13 peptide model system, and a new 
PAL-based Ca
2+
 titration assay was established in order to analyze the Ca
2+
 
sensitivity of photoadduct formation. The PAL experiments with the Munc13-derived 





/chelator buffer systems, followed by gel-electrophoretic analysis of 
the photoreaction products. After Coomassie-staining, the bands corresponding to 
CaM and the respective photoadducts were quantified with a near-infrared 
fluorescence imager on the basis of the Coomassie fluorescence. The quantification 
data from several independent experiments were pooled and plotted as a titration 
curve, from which the effective Ca
2+
 concentration range could be deduced. 
As pilot experiments employing free Ca
2+
 in the concentration range of 0-10 M 
indicated that photoadduct formation is induced already in the presence of 
nanomolar concentrations of free Ca
2+
, the PAL-based titration assays were carried 








formation of all Munc13-derived photoprobes was initiated already at free Ca
2+
 










Figure 15. PAL-based Ca
2+
 titration assay. (A, C, E) Representative Coomassie-stained SDS 













-13-3b after 20 min of irradiation in the presence of increasing 
free Ca
2+
 concentrations indicated below the gel images. For each photoprobe, quantification 
data from three independent PAL experiments with gels run in duplicate were pooled (n = 6) and 
plotted against the Ca
2+
 concentration to generate the titration curves shown in (B, D, F). To 
compensate for variations in the total protein load, relative photoadduct yields were calculated by 
dividing the intensity of the photoadduct band(s) by the summed up intensities of the CaM and 
photoadduct bands, and depicted in the graphs. Error bars indicate the standard deviation. (G) 
Coomassie-stained SDS gels showing the Ca
2+
-dependent photoadduct formation of Bpa
387
-
ub13-2 after 1 min of irradiation (upper panel), and of Bp
N
-ub13-2 after 20 min of irradiation 
(lower panel). Free Ca
2+







These results prompted the question whether the observed high Ca
2+
 sensitivities of 
photoadduct formation were a consequence of the non-equilibrium reaction 
conditions reached after extensive irradiation. Under these PAL conditions, the 
interaction partners are irreversibly transferred into a covalent complex and thereby 







-b13-2b, as these photoprobes showed an almost quantitative 
photoadduct yield at their optimum Ca
2+
 concentrations (Fig. 15A, 15C lower panel). 
To address this question the duration of irradiation was varied in time course studies 
in order to identify exposition times which left the majority of CaM unlabeled and 





 concentration sufficient to initiate photoadduct 
formation remained in the same range even when only 25 % of CaM took part in 
photoadduct formation after one minute of exposure to UV light (Fig. 15G, upper 
panel). 
Based on these observations it could be ruled out that the duration of irradiation, and 
thus the photoadduct yield, had a significant influence on the outcome of the titration 
experiments. Considering the significant influence of the anchor residue on peptide 
affinity to CaM as outlined above, there was a concern that the high Ca
2+
 
sensitivities of photoadduct formation might be an artifact due to incorporation of the 
photophores in position of the anchor residues. To address this issue, titration 
experiments were carried out under the same conditions using the N-terminally 
modified photoprobe Bp
N
-ub13-2 (Fig. 15G, lower panel). In agreement with the 
results obtained for Bpa
397
-ub13-2, the onset of photoadduct formation of Bp
N
-ub13-
2 was at the same nanomolar concentrations of free Ca
2+
, excluding the possibility 
that the position of the photophore within the peptide had a significant influence on 
the Ca
2+
 sensitivity of the interaction. 





-b13-2b exhibited an atypical Ca
2+
 dependence of 
photoadduct formation, as photoadduct yields peaked at approximately 30 nM free 
Ca
2+
, but dropped with higher Ca
2+
 concentrations (Fig. 15A upper panel, 15C lower 
panel). This observation was in clear contrast to the Ca
2+
 dependence of 









13-3b, which was represented by sigmoidal titration curves (Fig. 15B lower panel, 











independent CaM binding and tended to form secondary complexes of 1:2 
stoichiometry in the preceding PAL experiments (Fig. 13). However, it remains to be 
established whether these effects are all artifacts due to the use of model peptides 
or, at least in part, represent inherent properties of the corresponding full-length 
proteins Munc13-1 and bMunc13-2.  
Taken together, these findings indicated that Ca
2+
 concentrations as low as 20-30 
nM are sufficient to trigger binding of the Munc13-derived model peptides to CaM. 
However, these values should not be considered as absolutely exact as it is 
experimentally difficult to control nanomolar Ca
2+
 concentrations with chelator buffer 
systems, mainly due to contaminating Ca
2+ 
(Patton et al., 2004). In order to avoid 
that small changes in total Ca
2+
 due to contamination lead to drastic changes in free 
Ca
2+
 (Patton et al., 2004) higher chelator concentrations (10 mM EGTA) were used. 
To estimate the apparent Ca
2+
 contamination, aliquots of the virtually Ca
2+
-free 
samples (see lanes "0 nM free Ca
2+
" in Fig. 3 A) from all titration experiments were 
pooled and submitted for ICP-MS analysis of total Ca
2+
 concentration (measurement 
performed by Klaus Simon, University of Göttingen). The level of contaminating Ca
2+
 
was found to be in the 200 ppb range, which is equivalent to approximately 5 M 
Ca
2+
. Within the critical buffer range around 30 nM free Ca
2+
, this low level of 
contaminating Ca
2+
 would lead to only small increases in free Ca
2+
 (less than 10 %) 
in the presence of 10 mM EGTA (Patton et al., 2004).  
All PAL experiments described above employing bovine brain CaM have been 
reproduced with recombinant CaM showing no difference in photoadduct yield, 
complex stoichiometry and Ca
2+
 sensitivity (not shown). Therefore, recombinant 





3.1.6. Stoichiometry of the interaction of CaM with bMunc13-2 and Munc13-3 
The presence of two predicted CaM binding sites in bMunc13-2 and Munc13-3 
posed the question of what their function and mechanism of interaction with CaM 
might be. It was possible that the isoform-specific Munc13 peptides are recognized 
by different interaction sites on CaM and bind simultaneously, that they employ 
different CaM sites with only one being occupied at a time due to allosteric effects, 
or that they compete for the same binding pocket in CaM. To address this issue of 
binding site preference and occupancy in CaM by each pair of Munc13 peptides 
using PAL, CaM was incubated with an equimolar mixture of each Munc13-derived 
photoprobe pair.  Based on the SDS-PAGE analysis of the resulting photoadducts 
possibility for simultaneous binding of the two peptides to CaM was excluded as no 
trimeric photoadduct was observed (Fig. 16).  
 
 
Figure 16. PAL-based heterotrimer formation assay. Comparison of the binding pattern of an 









(B) with that of an equal total peptide concentration of each photoprobe independently, in the 





Rather, the photoadducts in the cross-linking reactions containing both photoprobes 
appeared like a combination between the two electrophoretic profiles observed in 
the PAL reactions employing each individual peptide. This outcome could not 
exclude any of the two remaining possible modes of interaction. Further experiments 
were designed to address the functional relevance and structural details of each 










3.1.7. Co-sedimentation assays with GST-fusion proteins of bMunc13-2(366-
780) and Munc13-3(711-1063) 
The PAL experiments detailed above were very useful for the identification and initial 
characterization of the novel CaM binding sites in the bMunc13-2 and Munc13-3 
isoforms but, as all peptide model systems, offered only limited insight into the 
behavior of individual domains in a full-length protein context. Thus, they did not 
resolve questions of significance, function and mechanism of the two CaM binding 
sites identified in each isoform. To address these questions GST-fusion protein 
fragments were designed that covered both predicted CaM binding sequences in the 
two proteins: bMunc13-2(366-780) and Munc13-3(711-1063). These constructs 
were used in co-sedimentation assays in order to verify their Ca
2+
-dependent 
binding to CaM and to examine the stoichiometry of these interactions. For that 
purpose GST-bMunc13-2(366-780) and GST-Munc13-3(711-1063) were 
immobilized on glutathione sepharose 4B beads and incubated with bovine brain 
CaM in the presence or absence of Ca
2+
. Following several washing steps the beads 
were boiled in sample buffer and the protein extracts were separated by SDS-PAGE 
and visualized by colloidal Coomassie staining. Both GST-bMunc13-2(366-780) and 
GST-Munc13-3(711-1063) interacted with CaM in a strictly Ca
2+
-dependent manner 
(Fig. 17), in contrast with the GST-Munc13-1(445-567) control construct which, as 
anticipated, exhibited also Ca
2+
-independent CaM binding (Junge et al., 2004). 
 
 
Figure 17. Co-sedimentation assays with 
GST-fusion proteins of bMunc13-2(366-
780) and Munc13-3(711-1063) 
Representative Coomassie-stained SDS gel 
showing CaM binding of the GST-fusion 
proteins of bMunc13-2(366-780) and Munc13-
3(711-1063) in the absence (-) and presence 
(+) of Ca
2+
. A GST-fusion construct of the 
CaM-binding site in Munc13-1 (445-497) was 
used as positive control. Mass spectrometric 
analysis of the 40 kDa protein species 
observed in the co-sedimentation assay of 
GST-bMunc13-2(366-780) showed that it 
corresponds to a truncated GST-bMunc13-2 
fragment not containing any of the 2 predicted 
CaM binding sites and was thus not 






Quantification of the Coomassie fluorescence signal from the bands corresponding 
to the GST-fusion proteins and the CaM co-sedimented under each condition (see 
section 2.4.2. in Methods) showed a 1:1 stoichiometry for these interactions 
suggesting that only one of the two predicted CaM binding sites in each isoform 
have functional relevance at the level of full length proteins. 
 
To determine which of the two CaM binding sequences is responsible for the 
interaction at the protein level different mutated GST-bMunc13-2(366-780) and 
GST-Munc13-3(711-1063) constructs were generated (Table 4) and tested for their 
Ca
2+
-dependent affinity for CaM. The constructs carried Arg mutations in place of 
the anchor Phe residues as these mutations were established as non-binding 
controls at the peptide level in the PAL experiments (see section 3.1.4.). 
 
Table 4. Mutant GST-fusion constructs of bMunc13-2(366-780) and Munc13-3(711-1063) 
used in the co-sedimentation assays. Respective mutations shown in superscript. 
 


























In the case of bMunc13-2, mutation of Phe580 to Arg did not impair CaM co-





 (Fig. 18A), indicating that only 







Figure 18. Co-sedimentation assays with GST-bMunc13-2(366-780) and its mutant variants. 














The Phe723Arg mutation in bMunc13-2 significantly reduces CaM binding but does 
not abolish it entirely. However, for the functional establishment and initial 
electrophysiological characterization of the bMunc13-2/CaM interaction in rescue 
experiments, a variant with complete loss of binding is required. Therefore, another 
GST-bMunc13-2(366-780) construct was designed where, together with the 
Phe723Arg, several amino acids making up the basic side of the amphiphilic helix 
that defines the CaM binding site were mutated to Glu (GST-bMunc13-
2
F723R/K724E/K728E/R731E
). These mutations led to complete disruption of binding to CaM 
(Fig. 18B) and were further considered in the design of viral vectors for neuronal 
infection and electrophysiological rescue experiments. 
 
When the mutations in the GST-Munc13-3(711-1063) were examined for their 
sensitivity to CaM it became clear that mutation of Phe787 to Arg has no effect on 
CaM binding, while Phe962 seems to be essential for the interaction, as its mutation 
to Arg led to complete loss of binding, also seen in the case where both anchoring 






Figure 19. Co-sedimentation assays with GST-Munc13-3(711-1063) and its mutant variants. 







 in the absence 




Thus, based on the co-sedimentation experiments it became clear that of the two 
predicted CaM binding sites in bMunc13-2 and Munc13-3 only the ones adjacent to 
the C1 domain of the proteins have functional relevance in the context of larger 
GST-fusion protein fragments. Despite lacking sequence homology with the 
characterized CaM binding sites in Munc13-1 and ubMunc13-2, these novel CaM 





3.2. Structural characterization of the Munc13/CaM interaction by PAL 
Elucidation of the molecular mechanisms underlying the regulation of Munc13 
proteins by CaM is greatly dependent on knowledge of the structure of the 
Munc13/CaM complexes. Such structural data have been missing so far, partly due 
to technical difficulties involving the production of recombinant full-length Munc13 
proteins. To circumvent this problem, a PAL-based analytical strategy using 
Munc13-derived photoprobes (see section 3.1.2.) was developed. For the initial 
establishment of this workflow (see below) the conserved CaM binding sites of the 
already functionally characterized Munc13 isoforms, Munc13-1 and ubMunc13-2 
(Junge et al., 2004) were employed. 
 
3.2.1. Analytical strategy 
The covalent complexes of the Munc13 photoprobes and CaM generated by PAL 
represent a suitable structural model of this interaction and, due to the design of the 














-13-3b all carry the photoactivatable Bpa moiety in place of their potential 
anchor residues (Trp or Phe) and, since this amino acid exchange preserves the 
hydrophobic, bulky, and aromatic characteristics of the anchor position, PAL should 
lead to a regioselective photoincorporation within the immediate binding cavity of 
CaM. Mass spectrometric analysis of the CaM/Munc13 complexes can provide direct 
identification of the amino acids of CaM involved in cross-link formation and thus in 
coordinating the anchor residue of the peptides. 
To implement this concept experimentally an innovative analytical strategy was 
established for the mapping of the sites of photoincorporation into CaM (Fig. 20). 
The workflow is characterized by the introduction of an MS-based dimension of 
separation by using two variants of recombinant CaM - "light" CaM produced under 
standard conditions (L-CaM) and "heavy" CaM metabolically labeled with 
15
N (H-













-13-3b while H-CaM 
was handled in parallel without being subjected to the reaction with the photoprobes. 
Following irradiation, labeled L-CaM and H-CaM were combined in an equimolar 
ratio and the resulting mixture was analyzed by gel electrophoresis and MS, and 
finally subjected to in-solution digest with trypsin. Because of the experimental 




theoretical peak patterns expected in the peptide survey spectra obtained by the 
HPLC/MALDI-MS analysis of the tryptic digests. Most of the signals should appear 
as characteristic doublet peaks with a fixed intensity ratio (ideally of 1:1) and a mass 
difference corresponding to the number of nitrogen atoms present in the respective 
CaM fragment. These would represent CaM sequences unaffected by the PAL 
reaction. The second signal pattern should be identical to the doublet peaks 
described above, with the exception that the "light" peak has an appreciably reduced 
intensity compared to its "heavy" counterpart. These would represent CaM 
sequences directly involved in photoadduct formation. The third species should be 
unpaired peaks with a natural isotope distribution. These masses are not compatible 
with tryptic CaM peptides and therefore represent fragments of the free photoprobe 
(which can be sorted out easily) or cross-linked peptides, consisting of the "down-
regulated" CaM fragment and the Bpa-containing fragment of the photoprobe. As 
off-line LC/MALDI-MS circumvents the time limitations of on-line LC/MS couplings, 
these cross-linked peptides could be subjected to extensive mass spectrometric 
sequencing or even to on-target manipulations such as CNBr cleavage. 
 
Figure 20. Analytical strategy for mapping the sites of photoincorporation into CaM. The 
experimental design is based on the use of normal "light" CaM (L-CaM) as binding partner for the 
photoprobe (PP) and 
15
N-labeled "heavy" CaM (H-CaM) as reference protein, both of which are 
combined after irradiation. The resulting mixture (containing L-CaM, H-CaM, the photoadduct 
(PA), and unreacted PP) was analyzed by gel electrophoresis (GE) and MS, and finally subjected 
to in-solution digest followed by HPLC/MALDI-MS analysis. Three defined peak patterns were 
expected in the peptide survey spectra: (i) CaM fragments not involved in photoadduct formation 
appear as "light" (L) and "heavy" (H) doublets of similar abundance, (ii) L-CaM fragments 
involved in photoadduct formation are less abundant compared to their H-CaM counterparts, and 




3.2.2. Detection of intact CaM complexes  
Due to the complexity of the analytical strategy described above, only the 
photoadducts of Munc13-1 and ubmunc13-2 were initially selected for structural 
analysis. As a first step in this analytical workflow CaM was incubated at 
physiological concentrations (5 M) with equimolar amounts of Bpa464-13-1 or 
Bpa
387
-ub13-2 in the presence of 30 nM free Ca
2+
, a concentration deduced as 
optimal from the Ca
2+
 titration experiments (Fig. 20), and the reaction was subjected 
to UV light for PAL. Using SDS-PAGE, a Ca
2+
-dependent complex of CaM with the 
photoprobe was detected as a band of an apparent molecular weight of 20 kDa (Fig. 
21 insets). The high photoadduct yields of at least 50 % were in agreement with the 
Ca
2+
 titration experiments using bovine brain CaM described earlier (See Fig. 15). 
MS was used to show that the homogenous gel bands corresponding to fractions of 
unreacted CaM indeed contained a mixture of L-CaM and H-CaM, differing by 177 
mass units. While the signals for L-CaM and H-CaM were of similar abundance 
when PAL was performed in the absence of Ca
2+
, the intensity of the signal for L-
CaM is considerably reduced upon PAL in the presence of Ca
2+
 (Fig. 21). The 
corresponding photoadducts of L-CaM were detected at their expected m/z values, 
though not with the expected abundance, which probably reflects selective losses of 
the more hydrophobic complexes during ZipTip desalting prior to MS. 
 
 
Figure 21. Detection of intact photoadducts by SDS-PAGE and MS. In the Coomassie-stained 
SDS gels (insets), the CaM photoadducts (PA) of Bpa
464





-dependently at an apparent molecular mass of 20 kDa. Due to experimental 
design (see Fig. 20), the CaM band contained L-CaM and H-CaM, which could not be distinguished by 
SDS-PAGE (mass difference 177 Da). This was possible by MS as shown in the mass spectra of the 
same fractions. Upon PAL in the presence of Ca
2+
, the signals for L-CaM dropped from equiabundant 
levels (not shown) to drastically reduced intensities compared to those of H-CaM. This was due to the 
involvement of L-CaM in the formation of photoadducts, which were detected at their expected m/z 
range (underlined in grey). Due to the use of sinapinic acid as matrix, all mass signals showed an 




3.2.3. Identification of cross-linked peptides 
As follows, the detailed detection and characterization of the cross-linked peptides is 
exemplified with the data acquired for the Munc13-1/CaM complex for the sake of 
conciseness. According to the analytical strategy (Fig. 20), the photoreaction mixture 
containing L-CaM, H-CaM, the photoadduct, and unreacted photoprobe was next 
subjected to a tryptic digest followed by HPLC/MALDI-MS analysis. In the peptide 
survey spectra obtained, most tryptic CaM fragments were detected as 
equiabundant doublet signals, corresponding to a CaM sequence coverage of at 




Figure 22. Peptide mapping of recombinant CaM by mass spectrometry. Detected tryptic 




These doublet signals consisted of a "light" peak derived from L-CaM involved in 
PAL and an equiabundant "heavy" peak derived from H-CaM included as reference 
protein, as shown as an example for CaM(78-86) (Fig. 23A). Consistent with the 
peptide sequence DTDSEEEIR containing 12 nitrogen atoms, the observed mass 





Figure 23. Identification of cross-linked peptides by HPLC/MALDI-MS. Selected peptide 
survey spectra showing characteristic peak patterns for a CaM fragment not involved in 
photoadduct formation (CaM(78-86), [M+H]
+
calc,mono = 1093.46/1105.40) (A), CaM fragments 
involved in photoadduct formation (CaM(116-126), [M+H]
+
calc,mono = 1349.63/1363.62) (B) and 
(CaM(127-148), [M+H]
+










calc,mono = 3213.45) (E). For the CaM fragments, the light-to-heavy ratios (L/H) were 
calculated on the basis of the peak areas of the entire isotope clusters. Isotope distributions of 
the simulated peaks (shown as filled red signals) were calculated with the MS-Isotope tool using 
the resolution of the corresponding observed peaks. For simulating the isotope distributions of H-
CaM-related peaks, incorporation of 
15
N was set to 98.7 %. In panels D and E, the signals at m/z 
2089.13 and 3229.66 did not display the typical isotope distribution of an H-CaM fragment and 
were assigned as the Met sulfoxide variant of the respective cross-linked peptide (monoisotopic 




The atypical isotope distribution observed in peaks corresponding to H-CaM tryptic 
peptides (see "heavy" peaks in the mass spectra of Fig. 23) is due to the incomplete 
incorporation of 
15
N into CaM (98.7 %, as determined on the basis of simulated 
isotope distributions). This incomplete isotope incorporation turned out to be an 
advantage, as a signal could be readily assigned as "light" or "heavy" just on the 
basis of its characteristic isotope distribution without the need to know the mass 
distance to its respective counterpart. When the mass spectra were screened for 
doublet signals with reduced intensity of the "light" peak compared to its "heavy" 
counterpart, such a peak pattern was observed for CaM(116-126) (ratio light/heavy 
= 0.75;Fig. 23 B) and CaM(127-148) (ratio light/heavy = 0.66; Fig. 23 C), indicating 
that Bpa
464
-13-1 labeled CaM in its C-terminal domain. The corresponding cross-
linked peptides consisting of one of the "down-regulated" CaM fragments CaM(116-
126) or CaM(127-148) and the Bpa-containing photoprobe fragment Bpa
464
-13-1 (5-
9) were detected as unpaired peaks with a natural isotope distribution at m/z 
2073.14 ([M+H]+calc,mono = 2073.00; Fig. 23 D) and m/z 3213.63 ([M+H]+calc,mono = 
3213.45; Fig. 23 E), respectively. Similarly, characteristic peak patterns with reduced 
intensity of the "light" peak for CaM(116-126) (ratio light/heavy = 0.88) and 
CaM(127-148) (ratio light/heavy = 0.61) were found when Bpa
387
-ub13-2 was used 
for PAL. The corresponding cross-linked peptides modified by Bpa
387
-ub13-2(5-9) 
were detected at m/z 2130.18 ([M+H]+calc,mono = 2130.00) and m/z 3270.68 
([M+H]+calc,mono = 3270.45). Based on the observation that the "light" peak of 
CaM(127-148) was always more markedly reduced in intensity than that of 
CaM(116-126), the outermost C-terminus of CaM was considered as the major, and 





2. Thus, the workflow allows for a semi-quantitative estimation of binding-site usage. 
 
Although not elaborated further here, corresponding analysis of the CaM 
photoadducts with the bMunc13-2- and Munc13-3-derived photoprobes showed 
down-regulation of the tryptic CaM peptides, CaM(116-126) and CaM(127-148), as 
well (data not shown). This finding was considered as sufficient evidence that all 
Munc13 isoforms share the same binding site in the C-terminal domain of CaM. 
Therefore, the focus on Munc13-1 and ubMunc13-2 was maintained for the further 
characterization of the cross-linked peptides. As above, the strategy is exemplified 





3.2.4. Identification of contact sites between Munc13 and CaM by PAL 
Following the detection of cross-linked peptides these were further analyzed by 
MS/MS sequencing in order to identify the amino acids in CaM labeled by the 
Munc13-derived photoprobes. In the case of Bpa
464
-13-1 the smaller cross-linked 
peptide Bpa
464
-13-1(5-9)-CaM(116-126) yielded a conclusive fragment ion series, 
which was best compatible with a linkage of Bpa
464
-13-1(5-9) to the side chain of 




Figure 24. Characterization of the photoadducts at the amino acid level. (A) Fragment ion 
mass spectrum of the cross-linked peptide Bpa
464
-13-1(5-9)-CaM(116-126). P denotes the 
precursor ion ([M+H]
+
calc,mono = 2073.00) and only b- and y-ions are labeled for the sake of clarity. 
While the N-terminal b-ion series excluded the amino acid stretch LTDEEVD as the site of 
modification, the y-ion series provided positive evidence that the photoprobe fragment Bpa
464
-13-
1(5-9) is linked through the side chain of Met-124 of CaM (marked by an asterisk). Note that the 
high abundance of the y8 and particularly of the y4 ion is in agreement with facile amide bond 
cleavages C-terminal of Asp. (B) Verification of Met124 cross-linking by on-target CNBr 
cleavage. CNBr treatment of the cross-linked peptide species Bpa
464
-13-1(5-9)-CaM(116-126) 
gave rise to a newly occurring signal representing the methylthiocyanate derivative of Bpa
7
-13-
1(5-9) (m/z 797.56, marked by an asterisk). The structure indicates the mass increment of 73 




In contrast, the fragment ion mass spectrum of the rather large cross-linked peptide 
Bpa
7
-13-1(5-9)-CaM(127-148) ([M+H]+calc,mono = 3213.45) did not contain instructive 
sequence information, but the few assignable signals indicated labeling of Met 
present in position 144 and 145. To test this further, the cross-link-containing sample 
spots were subjected to on-target CNBr cleavage. According to Kage et al. (Fig10; 
Kage et al., 1996), the bond between the -carbon and sulfur in the Met side chain is 
cleaved upon treatment with CNBr, which leads to the formation of a 
methylthiocyanate derivative and thereby release of the benzophenone-containing 
photoprobe fragment. This release happens only when photoincorporation has taken 
place into the terminal methyl group of a Met side chain and is indicated by the 
appearance of a specific signal at an m/z value 73 mass units higher than that of the 
unmodified photoprobe fragment (Kage et al., 1996). As a proof of principle, this 
method was first applied to the cross-linked peptide Bpa
464
-13-1(5-9)-CaM(116-126) 
and indeed detected the methylthiocyanate derivative of Bpa
464
(5- 9) (Fig. 24B). This 
result clearly demonstrated labeling of the side chain of Met-124 and was in full 
agreement with the MS/MS data (Fig. 24A).  
Next, the larger cross-linked peptide Bpa
464
-13-1 (5-9)-CaM(127-148) was subjected 
to on-target CNBr cleavage, leading to the complete disappearance of the signals at 
m/z 3213.63 and m/z 3229.66 corresponding to Bpa
464
-13-1(5-9)-CaM(127-148) and 







Figure 25. On-target CNBr cleavage of the cross-linked peptide Bpa
464
-13-1(5-9)-CaM(127-
148). The mass spectra were recorded from the same cross-link-containing sample spot prior to 
(- CNBr, upper panel) and after (+ CNBr, lower panel) on-target CNBr cleavage. The m/z range 
810 to 3150 was excluded from the x-axes to enable an appropriate display of the relevant parts 
of the mass spectra. Prior to cleavage, Bpa
464
-13-1(5-9)-CaM(127-148) (m/z 3213.63) and its Met 
sulfoxide variant (m/z 3229.66) were present together with the co-eluting free photoprobe 
fragment Bpa
464
-13-1(5-9) (m/z 724.34). After cleavage, the cross-linked peptide species 
disappeared completely, giving rise to the methylthiocyanate derivative of Bpa
464
-13-1(5-9) (m/z 
797.56, marked by an asterisk). 
 
Interestingly, MS/MS sequencing revealed that this signal corresponded to Bpa
464
-
13-1 (5-9) (Fig. 26), indicating that the free photoprobe fragment Bpa
464
-13-1 (5-9) 
co-eluted with the cross-linked peptide Bpa
464






Figure 26. Fragment ion mass spectra of the photoprobe fragment Bpa
464
-13-1(5-9) (A) and 
its methylthiocyanate derivative (B). P denotes the precursor ions. The identities of both 
peptides were confirmed on the basis of the conclusive fragment ion series obtained. In the 
amino acid sequences, F' indicates p-Benzoyl-Phe (Bpa) and F* its methylthiocyanate derivative. 
Note the presence of the corresponding immonium ions at m/z 224.19 (indicating F' in A) and m/z 
297.19 (indicating F* in B). In mass spectrum B, the signal at m/z 738.39 most likely corresponds 
to the loss of thiocyanic acid from the precursor. 
 
 
As the presence of the free photoprobe fragment was not a general feature of cross-
link-containing fractions, its release from the cross-linked peptide during mass 
spectrometric analysis was considered rather unlikely, an assumption further 
supported by the fact that benzophenones almost exclusively form stable C-C bonds 
(Dorman and Prestwich, 1994). More importantly, a newly appearing signal at m/z 
797.56 was detected (Fig. 25) and confirmed by MS/MS sequencing to correspond 
to the methylthiocyanate derivative of Bpa
464
-13-1(5-9) (Fig. 26). Thereby, labeling of 
CaM at Met-144/145 was demonstrated. Labeling of CaM at Met-124 and Met-






Thus, in complement with MS/MS sequencing, the on-target CNBr cleavage 
emerged as a useful method to test for photoincorporation at Met residues, when the 
cross-linked peptides were too large for a conclusive MS-based sequence analysis. 
An alternative approach to confront the large size of the photoadducts - the use of 
endoproteinase AspN in combination with trypsin for shortening the cross-linked 
peptides – was not practical in this study for several reasons. CaM appeared to be 
hardly accessible for AspN. Together with the unusual abundance of potential AspN 
cleavage sites (17 Asp and 21 Glu residues), this led to a variety of incomplete 
digestion products. As a consequence, the cross-link was distributed into several 
peptides, which often complicated or even prevented the identification of cross-
linked peptides. Moreover, incomplete cleavages often hampered the recognition of 
the characteristic peak patterns, which in our experimental design indicated the 
involvement of a particular CaM fragment in cross-link formation (see above). 
 
 
In summary, the structural characterization of the Munc13/CaM interaction by PAL 
revealed that Munc13 binding takes place in the C-terminal domain of CaM where 
the coordination of the hydrophobic anchor residue in Munc13 is achieved by key 
Met residues. The PAL methodology, however, was limited in providing structural 
information concerning the global orientation of the peptides in the complex and the 
overall CaM fold. These issues were further investigated in the framework of two 
collaborative studies. The question of peptide orientation was addressed by 
chemical cross-linking experiments involving the short Munc13-1 and ubMunc13-2 
peptides and CaM (as described in the discussion). For the elucidation of the overall 
structure of the Munc13/CaM complex, a combination of PAL and NMR experiments 




3.3. PAL and structural characterization of the CaM interaction of C-terminally 
elongated Munc13-1- and ubMunc13-2-derived peptides 
In the timeline of this study, a collaboration was initiated with Fernando Rodríguez-
Castañeda and colleagues from the Department for NMR-Based Structural Biology 
at the Max Planck Institute for Biophysical Chemistry (MPI-BC) (Göttingen) who are 
investigating structural aspects of the Munc13/CaM interaction by NMR methods. 
They used a 34 amino acid Munc13-1-derived peptide (further C-terminally 
elongated compared to the established CaM binding site; Junge et al., 2004) in NMR 
titration experiments with CaM to address the structural dynamics of binding 
between Munc13-1 and CaM. These experiments provided evidence that the 
Munc13-1 peptide may bind to CaM through two independent domains – a 
“classical” interaction involving the anchor Trp464 residue and the hydrophobic 
binding pocket in the C-terminal lobe of CaM (as seen in the PAL-based structural 
analysis described in section 3.2.), as well as a “novel” contact of Leu488 and 
Trp489 (positions 25/26 relative to the anchor Trp residue in position 464) with the 
side chains of Met36, Val55 and Ile 52 in the N-terminus of CaM ((Rodriguez-




Figure 27. Amino acid sequences of the model peptides covering the extended CaM 
binding sites in Munc13-1 and ubMunc13-2. Trp residues shown in red were substituted with 
p-Benzoyl-Phe (Bpa) individually or simultaneously to generate photoreactive peptides for PAL 
experiments. The sequences of the peptides used in the initial structural characterization of the 
Munc13/CaM complexes (see section 3.2.) are shown in parallel. 
 
To support this observation biochemically using the PAL methodology, Trp464, 
Trp489, or both were substituted with Bpa in Munc13-1(459-492)-derived peptide 













) photoprobes. As seen 
with the short photoprobes carrying Bpa in place of Trp464 (Bpa
464





 interacted with CaM specifically, with a 1:1 stoichiometry, and in a 
largely Ca
2+
-dependent manner, with some observable Ca
2+
-independent 










 (Fig. 28), validating the 
presence of the novel CaM binding element in Munc13-1 indicated by the NMR 





 implied that the binding of the C-terminal of Munc13-1
459-492
 is less tight than 




Figure 28. Photoaffinity labeling of CaM with Munc13-1(458-492)-derived photoprobes. 













 in the absence and presence of excess Ca
2+
 (1 mM). 
Photoprobe binding was considered specific as PA formation is suppressed in presence of ten-
fold molar excess of wild type competitor. Like in Fig. 13 mass spectrometry (not shown here) 
revealed that only unlabeled CaM and 1:1 photoadduct species were present even in the 
samples showing photoadduct double bands, which were most likely due to conformational 
effects on electrophoretic mobility. The 1:2 photoadduct species detected to some extent at an 
apparent molecular mass of 28 kDa were probably related to the artificially high Ca
2+
 
concentration of 1 mM, as these artifacts were not observed under physiological Ca
2+
 














 at free Ca
2+
 concentrations in the lower 
nanomolar range (Fig. 29), reproducing the effective Ca
2+
 concentrations observed 
for the CaM interactions of the shorter Munc13 derived CaM binding peptides (Fig. 
14). Further structural characterization of the photoadducts of the extended Munc13-
derived photoprobes was therefore performed on PAL reactions that had been 







Figure 29. PAL-based Ca
2+
 titration assay. Representative Coomassie-stained SDS gels 








 after 20 min of 
irradiation in the presence of increasing free Ca
2+
 concentrations as indicated below the gel 
images. 
 









 were subjected to the newly established workflow for the structural 
characterization of CaM photoadducts described in section 3.2. in order to confirm 






) Munc13-1-derived peptides. Indeed, mass spectrometric analysis 
showed that Trp464 reproducibly contacts Met124 and Met144 of CaM during 
binding, irrespective of the length of peptide (cross-link identification, MS/MS 
sequencing and CNBr digest results identical to Bpa
464
-13-1, therefore omitted 
here).  
To identify the contact sites of Trp489 of Munc13-1
459-492
 in CaM, the photoadducts 




 were characterized 
structurally as above. Trypsin digestion followed by HPLC/MALDI-TOF-MS revealed 
that the site of photoincorporation of Bpa489 into CaM is located within the tryptic 
peptide CaM
38-74







 has a mass of 4.9 kDa and is therefore 
not available for mass spectrometric sequencing, it was isolated by HPLC and 
truncated further by proteolysis with the endoproteinase AspN . By this approach, 
the site of photoincorporation was narrowed down to CaM
50-57
, and MS/MS 
sequencing of the cross-linked peptide revealed a linkage between Bpa489 of the 









state, Trp489 of Munc13-1
459-492
 contacts Met51 of CaM, a residue that is also part 
of the hydrophobic cleft of the N-terminal CaM domain as are the residues that 








 and CaM at the 







. P denotes the precursor ion ([M+H]
+
calc = 1707.79) and primed ion 
designators indicate fragmentation in the photoprobe chain. After an immediate loss of water (P-
H2O), a conclusive N-terminal b-ion series is formed, demonstrating that the sequence CaM
52-57
 
(INEVDA) was not modified. As modification of Asp50 can be ruled out on the basis of the AspN 
cleavage specificity, only Met51 remains as site of photoincorporation (see inset, F* encodes 




 and may 
be explained by concurrent release and radicalic rearrangement of the benzophenone moiety 
under post-source decay conditions (Leite et al., 2003). 
 
Comparison of the sequences of Munc13-1 and ubMunc13-2 in the region of their 
CaM recognition motifs showed that, apart from the high homology and the 
conserved distribution of hydrophobic residues in their established CaM binding 
sites, they also share the Trp in position 26 relative to the anchor Trp residue (Fig 
27). The sequence surrounding Trp412 in ubMunc13-2, however, is less 
homologous to Munc13-1, and is characterized by the presence of three non-
conserved Pro residues, amino acids known to have profound influence on the 
secondary structure of proteins. This raised the question whether the proposed 
novel CaM recognition motif is common to both Munc13 isoforms, despite the 
differences present in primary structure. To address this, photoprobes derived from 
the sequence of ubMunc13-2(382-415) where Trp387, Trp412, or both were 



















Figure 31. Photoaffinity labeling of CaM with ubMunc13-2(382-415)-derived photoprobes. 













 in the absence and presence of excess Ca
2+
 (1 
mM). Photoprobe binding was considered specific as PA formation is suppressed in presence of 
ten-fold molar excess of wild type competitor. Like in Fig. 13 mass spectrometry (not shown here) 
revealed that only unlabeled CaM and 1:1 photoadduct species were present even in the 
samples showing photoadduct double bands, which were most likely due to conformational 
effects on electrophoretic mobility. The 1:2 photoadduct species detected to some extent at an 
apparent molecular mass of 28 kDa were probably related to the artificially high Ca
2+
 
concentration of 1 mM.  
 
As observed for Munc13-1(459-492), CaM photoadducts of the longer ubMunc13-
2(382-415)-derived photoprobe carrying Bpa in place of Trp387 showed an 





photoprobe (Fig. 13). This identity could be reproduced in the MS-based structural 
analysis of the covalent photoadducts as it confirmed that Trp387 of ubMunc13-2 
contacts Met124 and Met 144 in CaM and thus shares the same binding site in the 
C-terminal domain of CaM with Trp
464
 of Munc13-1 (see section 3.2.3).  




 showed that the 
interaction through the Trp residue in position 26 relative to the anchor Trp387 is 
conserved between Munc13-1 and ubMunc13-2, and takes place with comparable 
efficiency (based on the similar photoadduct yields observed for the two isoforms 





and the analytical strategy described above led to the identification of a cross-linked 







indicating that the C-terminus also of ubMunc13-2
382-415
 bind to the N-terminal CaM 
domain. MS/MS sequencing of the cross-linked peptide revealed a linkage between 
Bpa412 of the photoprobe and Met71 of CaM (Fig. 32), a finding that was also 




 (data not shown). 
Thus, in the bound state, Trp412 of ubMunc13-2
382-415












 and CaM at the 







. P denotes the precursor ion ([M+H]
+
calc = 2890.30) and primed ion 
designators indicate fragmentation in the photoprobe chain. The detection of a C-terminal y- (y1-
y3) and an N-terminal b-ion series (b2-b7) revealed Met71 as the site of photoincorporation (see 
inset, F* encodes Bpa). Within the enlarged region m/z < 1000, fragment ions derived from 
cleavages in the photoprobe chain are only marked by an asterisk for the sake of clarity. The high 
abundance of the y9' ion at m/z = 2487.63 is in agreement with facile amide bond cleavages N-
terminal of Pro and C-terminal of Asp. 
 
 
In summary, the PAL-based analytical workflow for the structural characterization of 
CaM photoadducts established here was successfully employed for the biochemical 
verification of the novel mode of interaction, which was indicated for the 
CaM/Munc13-1 complex on the basis of dynamic NMR experiments. Furthermore, 
the PAL strategy was fast and efficient in providing evidence that this novel mode of 
interaction with CaM holds true for the ubMunc13-2 isoform, as well, a finding that 






4.1. Munc13 proteins interact with CaM via structurally distinct non-conserved 
binging sites 
Genetic, morphological, cell-biological, biochemical and electrophysiological 
evidence accumulated over the past decade has led to the notion of an essential 
role of the Munc13 proteins in synaptic transmission, at the step of maturation of 
docked synaptic vesicles to a fusion-competent state (Aravamudan et al., 1999; 
Augustin et al., 1999b; Betz et al., 1998; Brose et al., 2000; Maruyama and Brenner, 
1991; Richmond et al., 1999; Varoqueaux et al., 2002). Functional analyses have 
been focused mainly on Munc13-1, the isoform present throughout the brain, and 
the ubiquitously expressed isoform ubMunc13-2, while less information is available 
on the two other known Munc13 variants – the brain-specific bMunc13-2, and 
Munc13-3. The major interest in Munc13-1 is easily justified by its indispensable role 
in priming of synaptic vesicles at glutamatergic synapses – loss of Munc13-1 leads 
to a 90% reduction in the pool of readily releasable vesicles and a corresponding 
decrease in neurotransmission (Augustin et al., 1999b). In contrast, lack of Munc13-
2 or Munc13-3 alone does not cause strong phenotypic changes, implying that their 
function may be largely redundant with that of Munc13-1 (Augustin et al., 2001; 
Varoqueaux et al., 2002). 
Genomic, cDNA and protein sequence comparison of the members of the Munc13 
family showed that their general structure comprises two distinct modules: a C-
terminal unit, highly conserved across isoforms, and a largely variable N-terminal 
unit, bearing homology only in Munc13-1 and ubMunc13-2 (Betz et al., 2001; Brose 
et al., 1995b; Brose et al., 2000; Varoqueaux et al., 2002). The high conservation of 
the C-terminal module is an indication that its sequence has been subject to string 
selection pressure because it contributes to the essential functions of the Munc13 
proteins. This notion has been supported by more recent studies showing that the 
isolated C-terminal module of Munc13 is sufficient for the priming of synaptic 
vesicles (Basu et al., 2005; Stevens et al., 2005). However, the priming efficiency of 
such isolated C-terminal constructs is significantly lower than observed for the full-
length protein, indicating that further structures within the N-terminal part of Munc13s 
have important facilitating and modulating roles in Munc13 function. Thus, while 
bMunc13-2 and Munc13-3 are not, by themselves, essential for synaptic 
transmission in the presence of Munc13-1, they may, through their differing N-




platform for further specific regulation of priming and modulation of synaptic 
strength.  
Munc13-1 and ubMunc13-2 have emerged as key regulators of adaptive 
mechanisms defining short-term plasticity characteristics of neurons(Rosenmund et 
al., 2002). They contain a conserved calmodulin (CaM) binding site in their N-termini 
and the Ca
2+
-dependent interaction of these Munc13 isoforms with CaM constitutes 
a molecular mechanism that transduces residual Ca
2+
 signaling to the synaptic 
exocytotic machinery (Junge et al., 2004). To address the question whether such 
Ca
2+
/CaM regulatory mechanisms are present in the bMunc13-2 and Munc13-3 
isoforms, bioinformatics tools were used for the identification of potential non-
conserved CaM recognition motifs in their non-homologous N-terminal sequences. 
The in silico analysis led to the prediction of two potential CaM-binding sequences in 
each isoform and these were used as templates for the synthesis of Munc13-derived 
model peptides to be used in photoaffinity labeling (PAL) experiments with CaM. 
These peptides were designed such that their proposed anchor residues (Trp or 
Phe) for CaM binding were replaced with the photoreactive amino acid derivative p-
Benzoyl-Phe (Fig. 12). By applying this strategy, the photophore was directly 
introduced into the CaM binding site without changing the hydrophobic, bulky, and 
aromatic characteristics of the corresponding anchor position, thus minimizing 
interference with the biopotency of the peptides. The photoprobes covering 
established (for Munc13-1 and ubMunc13-2) and newly proposed (for bMunc13-2 
and Munc13-3) CaM binding sites were used in PAL experiments and mass 
spectrometric analysis to demonstrate their stoichiometric and Ca
2+
-dependent 
interaction with CaM (Fig. 13). 
The bioinformatics prediction of two CaM binding sites in the N-termini of bMunc13-2 
and Munc13-3 and their confirmation at the peptide level in the PAL assays raised 
questions concerning the functional relevance of multiple CaM binding domains 
within the full-length Munc13 proteins. Based on co-sedimentation assays with 
recombinant protein constructs of ~40 kDa, containing both predicted CaM binding 
sites in bMunc13-2 and Munc13-3, it became evident that, for both isoforms, only 
the CaM binding site closest in position to the conserved central C1 domain has 
functional relevance within larger protein fragments, and, consequently, the full-
length proteins (Fig. 18 and 19). Thus, these experiments constitute the first 
biochemical proof that bMunc13-2 and Munc13-3 interact with CaM in  a 
stoichiometric and Ca
2+




assays illustrated both the strengths and limitations of bioinformatics tools for the 
prediction of protein/protein interactions and emphasized the need for biochemical 
cross-validation of predicted interactions in the context of at least larger protein 
fragments. While isolated shorter peptides may convey the optimal requirements for 
recognition by a target protein, structural factors brought about by other parts of the 
protein may have decisive influence on whether this interaction is physiologically 
feasible. 
In summary, the combination of bioinformatics sequence analysis, peptide-based 
PAL experiments and co-sedimentation assays with larger Munc13-derived protein 
fragments established the presence of non-conserved CaM binding sites in 
bMunc13-2 and Munc13-3, and demonstrated that these Munc13 isoforms bind CaM 
in a stoichiometric and Ca
2+
-dependent manner. Despite lacking homology with the 
characterized CaM binding sites in Munc13-1 and ubMunc13-2, these novel CaM 
interaction sites share the same position in the Munc13 sequence relative to the C1 
domain, indicating that they are a product of convergent evolution and convey to 
bMunc13-2 and Munc13-3 similar roles in processes of presynaptic STP.  
 
 
4.2. Munc13/CaM complex formation is triggered at Ca
2+
 concentrations in the 
lower nanomolar range 
Sensing of and response to transient increases in the residual presynaptic Ca
2+
 
levels are important adaptive mechanisms that define the short-term plasticity 
characteristics of neurons (Zucker and Regehr, 2002). The CaM/Munc13 interaction 
was put forward as a Ca
2+
 sensor/effector complex transducing residual Ca
2+
 
signaling to the exocytotic machinery at the presynapse, prompting questions 
regarding the Ca
2+
 sensitivity of formation of this complex. The PAL-based Ca2+ 
titration assay established in this study revealed that CaM binding of all four Munc13 
isoforms is sensitive to Ca
2+
 concentrations in the range of 20-30 nM (Fig. 15). 
Although these unexpectedly low Ca
2+
 concentrations may still be afflicted with 
some uncertainty due to technical limitations in controlling free Ca
2+
 in the 
nanomolar range, they can be considered as physiological on the basis of a recent 
study reporting basal presynaptic Ca
2+
 levels of as low as 25 nM (Korogod et al., 
2005). Indeed, Ca
2+
 affinities in the lower nanomolar range have been reported 
previously for other CaM/target peptide complexes (Murase and Iio, 2002; Olwin and 




shown that full-length CaM binding proteins require effective Ca
2+
 concentrations up 
to one order of magnitude higher than the corresponding peptides to induce CaM-
dependent effects (Crouch et al., 1981; Fitzsimons et al., 1992; Yagi et al., 1989). In 
agreement with these observations, a half-maximal effective Ca
2+
 concentration of 
approximately 100 nM has been recently determined for the binding of fluorescent 
full-length GFP-ubMunc13-2 to CaM-coated beads (Zikich et al., 2008). Considered 
in the context of synaptic function and plasticity at low Ca
2+
 concentrations, the Ca
2+
 
sensitivity of CaM interaction for all Munc13 isoforms reported here indicates that 
bMunc13-2 and Munc13-3 may have STP characteristics similar to those previously 
established for Munc13-1 and ubMunc13-2(Junge et al., 2004). Thus, all Munc13 
proteins and CaM form Ca
2+
 sensor/effector complexes, which are functional already 
at slightly elevated Ca
2+
 levels and capable of sensing small increases in 
presynaptic Ca
2+
 concentration, that are thought to be necessary for the induction of 
STP phenomena (Korogod et al., 2005).  
So far, neither bMunc13-2 nor Munc13-3 have been studied in detail at the 
functional level. However, preliminary data indicate that both isoforms convey Ca
2+
-
dependent STP characteristics to synapses, much like ubMunc13-2 (J.-S. Rhee, 
unpublished observations). Future experiments will have to determine whether the 
STP characteristics conveyed by bMunc13-2 and Munc13-3 are caused by the 
Ca
2+
/CaM binding sites characterized in the present study. 
 
 
4.3. Structural characterization of the Munc13/CaM interaction  
4.3.1. A novel PAL- based strategy for interaction site mapping  
The new PAL-based workflow for the structural characterization of peptide/protein 
interactions established in this study comprises the use of benzophenone 
photoprobes, an isotopically labeled target protein (here CaM), and mass 
spectrometry for an in-depth analysis of the photoadducts (Fig. 20). Within the 
experimental strategy, typical shortcomings of more common PAL workflows have 
been addressed, which are often related to (i) photoprobe design, (ii) identification of 
the cross-linked peptides (i.e. localization of the region of photoincorporation), and 
(iii) sequence analysis of the cross-linked peptides (i.e. identification of the exact site 
of photoincorporation). First, photoprobe design is facilitated by the use of Bpa as 
this photoreactive amino acid can replace the hydrophobic, bulky, and aromatic 




without changing the overall biophysical properties of the peptide. Bpa substitution 
of the anchor residues promotes regioselective photoincorporation within the 
immediate binding cavity of CaM and thereby facilitates the direct identification of 
the amino acids of CaM involved in coordinating the anchor residue of the peptides. 
Moreover, benzophenones have a unique photochemistry, allowing for reversible 
activation even in the presence of water (Dorman and Prestwich, 1994), and are 
therefore the photophores of choice when high photoadduct yields are required to 
obtain enough material for subsequent analysis. Second, identification of the cross-
linked peptides is facilitated by the inclusion of isotopically labeled CaM (H-CaM) as 
reference protein. Due to this experimental design, CaM sequences involved in 
photoadduct formation are represented by doublet peaks, the "light" peak of which 
has a reduced intensity compared to its "heavy" counterpart. Accordingly, candidate 
masses of corresponding cross-linked peptides can be easily derived and the mass 
spectra can be screened for such masses appearing as unpaired peaks with natural 
isotope distributions. When different CaM fragments are involved in photoadduct 
formation, the regulation factor of the L-CaM/H-CaM doublet peaks contain semi-
quantitative information of binding-site usage, which cannot be derived from the 
mass spectrometric detection of the cross-linked peptide alone. Third, sequence 
analysis of the cross-linked peptides is facilitated by the use of off-line rather than 
on-line LC/MS techniques. Whereas the chromatographic peak width defines the 
analysis time in on-line couplings, LC/MALDI-MS is not limited in this respect and 
even enables on-target manipulations such as CNBr cleavage.  
In conclusion, this PAL-based workflow can find further use in the future research on 
novel CaM binding partners as it allows for a rapid structural screening of peptide-
CaM interactions when data on the atomic structure of the complexes are lacking. 
Applications can also be extended to other peptide-protein interactions, especially in 




4.3.2. CaM interacts with Munc13 through key Met residues  
Mass spectrometric analysis of the Munc13/CaM photoadducts showed that 
photoincorporation of the Bpa groups from the Munc13-derived photoprobes takes 




‘Met preference’ can be explained the observation that C-H bonds adjacent to 
heteroatoms are particularly reactive sites for photoincorporation of benzophenones 
(Dorman and Prestwich, 1994). In the case of Met, the thioether may be involved in 
the formation of an intermediate radical anion/cation pair to account for the high 
reactivity of the Met side chain (O'Neil et al., 1989). Consistently, labeling of Met 
side chains was found in numerous PAL studies using benzophenone-derivatized 
peptides (see (Behar et al., 2000; Kage et al., 1996; O'Neil et al., 1989; O'Neil and 
DeGrado, 1989; Sachon et al., 2003) and references therein). More importantly, 
however, CaM is an extraordinarily Met-rich protein (Met frequency of 6.1 %), and 
the Met residues constitute virtually half of its hydrophobic binding interfaces that are 
exposed to the solvent upon Ca
2+
 binding (Peersen et al., 1997; Yamniuk and Vogel, 
2004). Consequently, essentially all Met side chains are involved in van der Waals 
interactions with the MLCK- and CaMKII-derived peptides as seen in the high-
resolution structures of these CaM complexes (Ikura et al., 1992; Meador et al., 
1992; Meador et al., 1993). The CaM residues shown here to be involved in cross-
linking with the Munc13 peptides - Met-124 and Met-144 – have been previously 
reported in initial PAL studies on CaM using artificial model peptides with Bpa in the 
N-terminus of a basic amphiphilic -helix (O'Neil et al., 1989; O'Neil and DeGrado, 
1989). In these studies, modeling approaches were used to demonstrate that, 
depending on the orientation of the Bpa residue, labeling occurred either at Met-124 
or Met-144, both of which line opposite sides of a hydrophobic cavity in the C-





(ubMunc13-2) into the side 
chains of Met-144 and Met-124 in CaM is an accurate correlate of the contact sites 
between CaM and the anchor Trp of Munc13-1 and ubMunc13-2. 
Taking together all lines of evidence obtained in the PAL experiments, it was 
postulated that, in the bound state, the anchor residues Trp-464 of Munc13-1 and 
Trp-387 of ubMunc13-2 contact Met-124 and Met-144 of CaM, the latter 









4.3.3. Integration of PAL and chemical cross-linking constraints for molecular 
modeling of the CaM/Munc13 complex 
The contacts revealed by PAL constituted exceptionally valuable constraints for 
molecular modeling as they were deduced from virtually "zero-length" cross-links. 
However, PAL approaches have the inherent limitation that they usually provide only 
a low number of constraints and have been insufficient to address questions 
regarding the orientation of the Munc13 peptides in the complex with CaM. For this 
reason, complementary chemical cross-linking experiments on the CaM/Munc13-1 





G, with spacer lengths of 11.4 Å and 7.7 Å, respectively. The different 
molecular distance constraints for Lys residues in CaM and the Munc13-1-derived 
peptides obtained in these chemical cross-linking experiments were combined with 
the constraints from PAL acquired in this study and used for the structural modeling 
of the CaM/Munc13-1 complexes. All chemical cross-linking (Inez Pottratz, Christian 
Ihling) and molecular modeling (Stefan Kalkhof) experiments were performed in the 
group of Prof. Andrea Sinz at the University of Halle. 
The Munc13-1 peptide (predicted to adopt an -helical structure, based on 
bioinformatics analysis and modeling) was docked to a variety of different CaM 
structures with simultaneous consideration of the constraints from PAL (Trp-C
2
-Met-
S distances of 0-8 Å) and chemical cross-linking (Lys-C-Lys-C-distances of 5-19 
Å). The best fit with the experimental data sets was obtained for the structure of 
CaM in complex with a peptide derived from neuronal NO synthase (nNOS, pdb 
entry 2O60) (Fig. 33). As a result of the combination of two complementary sets of 
constraints derived from different cross-linking techniques the modeled structures of 
CaM/Munc13 peptide complexes exhibited only subtle structural differences with an 
overall rmsd value of less than 5 Å. When only the constraints from PAL were 
applied for docking, numerous different orientations particularly of the peptide C-
terminus were obtained (Fig. 33B). In contrast, the overall orientation of the peptide 
was already quite well described on the basis of the relatively loose constraints from 
chemical cross-linking alone, but exact localization of the peptide N-terminus was 
not possible due to the lack of rather tight constraints from PAL (Fig. 33C). Further 
model refinement confirmed the structure of CaM from the CaM/nNOS peptide 





Figure 33. Molecular modeling of the Munc13-1/CaM complex. (A-C) Structures of the 
Munc13-1/CaM complex created by PatchDock on the basis of the constraints from PAL and 
chemical cross-linking (A), PAL alone (B), and chemical cross-linking alone (C). The structure of 
CaM from the CaM/nNOS peptide complex (pdb entry 2O60) as best-fitting structure is shown in 
green. Docking solutions for 13-1 are shown in gray and were limited to ten representative 
structures in (B). As shown in (A), only two peptide structures were possible (clustering rmsd < 5 
Å) when the constraints from PAL and chemical cross-linking are combined. For comparison, the 
structure of the nNOS peptide (pdb entry 2O60) is shown in red. (D) Model of the complex 
formed by Munc13-1 (blue) and CaM (gray) after structural refinement using the RosettaDock 
server. The color code of the Lys residues is as follows: CaM Lys-77/94, yellow; CaM Lys-21/75, 
red; 13-1 Lys-4/13, purple. The amino acid side chains involved in PAL (Trp-7 of 13-1 and Met-
124/144 of CaM) are presented in green. Visualization was performed by PyMol. Figure courtesy 





Corresponding chemical cross-linking experiments and subsequent molecular 
modeling of the ubMunc13-2/CaM interaction revealed an antiparallel orientation 
and similar overall conformation of this complex to the one observed for Munc13-1. 
 
Thus, due to the complementary nature of PAL and chemical cross-linking, insights 
were gained into both binding sites (mainly by PAL) and overall conformations 
(mainly by chemical cross-linking) of CaM in complex with Munc13-1. Based on the 
integration of all molecular distance constraints, a molecular model of this interaction 
was proposed, which, despite its low resolution, provides important structural 
information: CaM and the Munc13 proteins interact in an antiparallel orientation 
through a 1-5-8 motif. In the energetically most likely structure CaM adopts a fold 
similar to the one reported for its complex with neuronal NOS (pdb entry 2O60). 
NOS (like MLCK) contains a so-called 1-5-8-14 CaM binding motif, indicating the 
presence of hydrophobic anchor amino acids in positions 1, 5, 8, and 14 of the motif 
(Rhoads and Friedberg, 1997). Munc13-1 and ubMunc13-2 exhibit a similar CaM 
binding motif, with hydrophobic amino acids in positions 1, 5, 8, 10 and 12 (Fig. 6). 
However, the hydrophobic residue in position 14 of the CaM binding motif is missing, 
as is the N-terminal cluster of basic amino acids, which usually determines the 
orientation of the target protein in the CaM complex (Vetter and Leclerc, 2003). This 
led to the conclusion that Munc13 has an unusual motif with a CaM binding mode 
similar, but not identical to that of nNOS. Support for this conclusion comes from the 
molecular models, in which the C-terminus of 13-1 differs in its conformation from 
that of the NOS peptide as the charged Glu residue in position 14 of the motif cannot 
be accommodated in the hydrophobic cleft of the N-terminal CaM domain (Fig. 33A, 
33D). Due to the lack of tight PAL constraints for the C-terminal parts of the Munc13 
peptides, it cannot be ruled out that the N-terminal CaM domain may adopt a rather 
extended conformation while the peptides bind through the 1-5-8 motif to the C-
terminal CaM domain. Such a structure has been described for the complex formed 
by CaM and C20W, a peptide derived from plasma membrane Ca
2+
 pump (Elshorst 
et al., 1999). On the basis of the complementary cross-linking data the CaM binding 
motif of Munc13 could be unambiguously classified as a member of the antiparallel 
1-5-8 motif family, but high-resolution structural studies were needed to elucidate the 






4.3.4. The high-resolution structure of the CaM/Munc13 complex reveals a 
novel 1-26 CaM recognition motif 
The low-resolution structural model of CaM in complex with Munc13-derived 





-CaM complex in solution obtained recently by Fernando 
Rodriguez-Castañeda and colleagues at the Department for NMR-Based Structural 
Biology of the MPI-BPC (Göttingen). Using C-terminally elongated peptides 
compared to the ones employed in the cross-linking approaches (Fig. 27), they 
showed that Munc13-1 interacts with the C-terminal domain of CaM in an antiparallel 
orientation through its hydrophobic anchor residues in positions 1-5-8. More 
interestingly, they observed a second module of Munc13/CaM interaction where the 
Trp residue in position 26 relative to the first hydrophobic anchor residue is attached 











saturated CaM (red) interacts with Munc13-1
458-492
 (black) in an open conformation. The complex 
features two modules: an amphiphilic -helical 1-5-8 motif bound to the CaM C-terminal domain 
and the 25-26 LW motif attached to the CaM N-terminal domain. The side-chains of the 
anchoring residues are highlighted as yellow sticks. Figure courtesy of Fernando Rodriguez-
Castañeda. 
 
Biochemical support for these structural features came from the PAL data on the 
Munc13-1
459-492
/CaM complex described herein, showing that Trp489 in position 1 of 
the 1-5-8-26 motif contacts Met124 and Met144 in the hydrophobic cleft of the C-




hydrophobic cleft of the N-terminal CaM domain (Fig. 30). This bipartite mode of 
interaction involving hydrophobic anchor residues at positions 1-5-8-26 seems to be 
conserved in ubMunc13-2 as well, as PAL revealed that the Trp residue in position 
26 of the ubMunc13-2 motif interacts specifically and in a Ca
2+
 dependent manner 
with Met71 in the N-terminal domain of CaM (Fig. 32). Met51 and Met71 are 
positioned at opposite sites of the hydrophobic cavity in the N-terminal lobe of CaM, 
indicating that Munc13-1 and ubMunc13-2 have a very similar, if not identical, mode 
of interaction with CaM in an extended conformation. The subtle difference in the 
CaM coordination of the C-terminal parts of the two Munc13-derived peptides most 
likely originates from the presence of three non-conserved Pro residues in 
ubMunc13-2 and their potential influence on secondary structure. 
 
In summary, the combination of different cross-linking techniques, mass 
spectrometry, and molecular modeling is a powerful tool to complement NMR and X-
ray crystallography. In the present example, this approach rapidly yielded structural 
information with a reasonable technical effort, and, most importantly, enabled the 
characterization of a peptide-protein interaction under physiological solvent and 
concentration conditions. 
CONCLUSIONS AND OUTLOOK 
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5. CONCLUSIONS AND OUTLOOK 
This study provides evidence for the presence of non-conserved CaM binding sites 
in the bMunc13-2 and Munc13-3 proteins. PAL and co-sedimentation experiments 
demonstrated that all four Munc13 isoforms bind CaM in a stoichiometric and Ca
2+
-
dependent manner and that only slightly elevated intracellular Ca
2+
 concentrations 
are sufficient to trigger these interactions. These findings support the conclusion that 
convergent evolution has generated structurally distinct but functionally similar 
Ca
2+
/CaM binding sites in Munc13-1/ubMunc13-2, bMunc13-2, and Munc13-3, all of 
which can contribute to presynaptic short term plasticity. On-going expression 
cloning and electrophysiological work is aimed at elucidating the role of the CaM 
regulation of bMunc13-2 and Munc13-3 in the context of short term plasticity. 
A PAL-based analytical strategy was established that allows for the rapid structural 
characterization of peptide/protein interactions. It is especially valuable in providing 
details about the binding sites accommodating such interactions and was applied 
here in the identification of critical Met side chains in the C-terminal domain of CaM 
that coordinate the anchor Trp residues of Munc13 proteins. Further integration of 
PAL and chemical cross-linking approaches allowed the generation of a molecular 
model of the Munc13/CaM complex demonstrating its antiparallel orientation. 
Moreover, the PAL methodology emerged as an important complement to high-
resolution NMR studies on the Munc13/CaM interaction, providing biochemical 
evidence for a novel 1-26 CaM binding motif in Munc13-1 and ubMunc13-2. 
The structural data on the CaM-Munc13 complex offer new options for future studies 
towards a deeper understanding of the role of the Munc13 proteins in synaptic 
vesicle priming and short-term plasticity. Structural information facilitates the design 
of Munc13 mutants with altered affinities for CaM, which, alongside the previously 
established CaM-insensitive variants (W464R in Munc13-1 and W387R in 
ubMunc13-2; Junge et al., 2004), will be extremely useful tools in the further 
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